<?xml version="1.0" ?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.3 20210610//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">elife</journal-id>
<journal-id journal-id-type="publisher-id">eLife</journal-id>
<journal-title-group>
<journal-title>eLife</journal-title>
</journal-title-group>
<issn publication-format="electronic" pub-type="epub">2050-084X</issn>
<publisher>
<publisher-name>eLife Sciences Publications, Ltd</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">90422</article-id>
<article-id pub-id-type="doi">10.7554/eLife.90422</article-id>
<article-id pub-id-type="doi" specific-use="version">10.7554/eLife.90422.2</article-id>
<article-version-alternatives>
<article-version article-version-type="publication-state">reviewed preprint</article-version>
<article-version article-version-type="preprint-version">1.4</article-version>
</article-version-alternatives>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neuroscience</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Large-scale characterization of cocaine addiction-like behaviors reveals that escalation of intake, aversion-resistant responding, and breaking-points are highly correlated measures of the same construct</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes" equal-contrib="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4782-7430</contrib-id>
<name>
<surname>de Guglielmo</surname>
<given-names>Giordano</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="author-notes" rid="n1">#</xref>
<email>gdeguglielmo@health.ucsd.edu</email>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Carrette</surname>
<given-names>Lieselot LG</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="author-notes" rid="n1">#</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kallupi</surname>
<given-names>Marsida</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Brennan</surname>
<given-names>Molly</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Boomhower</surname>
<given-names>Brent</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Maturin</surname>
<given-names>Lisa</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Conlisk</surname>
<given-names>Dana</given-names>
</name>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sedighim</surname>
<given-names>Sharona</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tieu</surname>
<given-names>Lani</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fannon</surname>
<given-names>McKenzie J</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Martinez</surname>
<given-names>Angelica R</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Velarde</surname>
<given-names>Nathan</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Othman</surname>
<given-names>Dyar</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sichel</surname>
<given-names>Ben</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ramborger</surname>
<given-names>Jarryd</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lau</surname>
<given-names>Justin</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kononoff</surname>
<given-names>Jenni</given-names>
</name>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kimbrough</surname>
<given-names>Adam</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Simpson</surname>
<given-names>Sierra</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Smith</surname>
<given-names>Lauren C</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shankar</surname>
<given-names>Kokila</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bonnet-Zahedi</surname>
<given-names>Selene</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sneddon</surname>
<given-names>Elizabeth A</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Avelar</surname>
<given-names>Alicia</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Plasil</surname>
<given-names>Sonja L</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mosquera</surname>
<given-names>Joseph</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Crook</surname>
<given-names>Caitlin</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chun</surname>
<given-names>Lucas</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vang</surname>
<given-names>Ashley</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Milan</surname>
<given-names>Kristel K</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Schweitzer</surname>
<given-names>Paul</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lin</surname>
<given-names>Bonnie</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Peng</surname>
<given-names>Beverly</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chitre</surname>
<given-names>Apurva</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Polleskaya</surname>
<given-names>Oksana</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Solberg Woods</surname>
<given-names>Leah C</given-names>
</name>
<xref ref-type="aff" rid="a4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Palmer</surname>
<given-names>Abraham A</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a5">5</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>George</surname>
<given-names>Olivier</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<email>olgeorge@health.ucsd.edu</email>
</contrib>
<aff id="a1"><label>1</label><institution>Department of Psychiatry, University of California, San Diego</institution>, <city>San Diego</city>, <country>USA</country></aff>
<aff id="a2"><label>2</label><institution>Department of Neuroscience, The Scripps Research Institute</institution>, <city>San Diego</city>, <country>USA</country></aff>
<aff id="a3"><label>3</label><institution>Institut de Neurosciences de la Timone, Aix-Marseille Université</institution>, <city>Marseille</city>, <country>France</country></aff>
<aff id="a4"><label>4</label><institution>Department of Internal Medicine, Section on Molecular Medicine, Wake Forest University School of Medicine</institution>, <city>Winston-Salem</city>, <country>USA</country></aff>
<aff id="a5"><label>5</label><institution>Institute for Genomic Medicine, University of California, San Diego</institution>, <city>San Diego</city>, <country>USA</country></aff>
</contrib-group>
<contrib-group content-type="section">
<contrib contrib-type="editor">
<name>
<surname>Day</surname>
<given-names>Jeremy J</given-names>
</name>
<role>Reviewing Editor</role>
<aff>
<institution-wrap>
<institution>University of Alabama at Birmingham</institution>
</institution-wrap>
<city>Birmingham</city>
<country>United States of America</country>
</aff>
</contrib>
<contrib contrib-type="senior_editor">
<name>
<surname>Wassum</surname>
<given-names>Kate M</given-names>
</name>
<role>Senior Editor</role>
<aff>
<institution-wrap>
<institution>University of California, Los Angeles</institution>
</institution-wrap>
<city>Los Angeles</city>
<country>United States of America</country>
</aff>
</contrib>
</contrib-group>
<author-notes>
<fn id="n1" fn-type="equal"><label>#</label><p>These 2 authors contributed equally</p></fn>
<fn id="n2" fn-type="conflict"><p>Funding and disclosure: The authors declare no conflict of interest.</p></fn>
</author-notes>
<pub-date date-type="original-publication" iso-8601-date="2023-09-14">
<day>14</day>
<month>09</month>
<year>2023</year>
</pub-date>
<pub-date date-type="update" iso-8601-date="2024-10-07">
<day>07</day>
<month>10</month>
<year>2024</year>
</pub-date>
<volume>12</volume>
<elocation-id>RP90422</elocation-id>
<history>
<date date-type="sent-for-review" iso-8601-date="2023-07-13">
<day>13</day>
<month>07</month>
<year>2023</year>
</date>
</history>
<pub-history>
<event>
<event-desc>Preprint posted</event-desc>
<date date-type="preprint" iso-8601-date="2023-07-13">
<day>13</day>
<month>07</month>
<year>2023</year>
</date>
<self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2021.07.22.453410"/>
</event>
<event>
<event-desc>Reviewed preprint v1</event-desc>
<date date-type="reviewed-preprint" iso-8601-date="2023-09-14">
<day>14</day>
<month>09</month>
<year>2023</year>
</date>
<self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.90422.1"/>
<self-uri content-type="editor-report" xlink:href="https://doi.org/10.7554/eLife.90422.1.sa3">eLife assessment</self-uri>
<self-uri content-type="referee-report" xlink:href="https://doi.org/10.7554/eLife.90422.1.sa2">Reviewer #1 (Public Review):</self-uri>
<self-uri content-type="referee-report" xlink:href="https://doi.org/10.7554/eLife.90422.1.sa1">Reviewer #2 (Public Review):</self-uri>
<self-uri content-type="referee-report" xlink:href="https://doi.org/10.7554/eLife.90422.1.sa0">Reviewer #3 (Public Review):</self-uri>
<self-uri content-type="author-comment" xlink:href="https://doi.org/10.7554/eLife.90422.1.sa4">Author Response</self-uri>
</event>
</pub-history>
<permissions>
<copyright-statement>© 2023, de Guglielmo et al</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>de Guglielmo et al</copyright-holder>
<ali:free_to_read/>
<license xlink:href="https://creativecommons.org/licenses/by/4.0/">
<ali:license_ref>https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="elife-preprint-90422-v2.pdf"/>
<abstract>
<title>Abstract</title>
<p>Addiction is commonly characterized by escalation of drug intake, compulsive drug seeking, and continued use despite harmful consequences. However, the factors contributing to the transition from moderate drug use to these problematic patterns remain unclear, particularly regarding the role of sex. Many preclinical studies have been limited by small sample sizes, low genetic diversity, and restricted drug access, making it challenging to model significant levels of intoxication or dependence and translate findings to humans. To address these limitations, we characterized addiction-like behaviors in a large sample of &gt;500 outbred heterogeneous stock (HS) rats using an extended cocaine self-administration paradigm (6 h/daily). We analyzed individual differences in escalation of intake, progressive-ratio (PR) responding, continued use despite adverse consequences (contingent foot shocks), and irritability-like behavior during withdrawal. Principal component analysis showed that escalation of intake, progressive ratio responding, and continued use despite adverse consequences loaded onto a single factor that was distinct from irritability-like behaviors. Categorizing rats into resilient, mild, moderate, and severe addiction-like phenotypes showed that females exhibited higher addiction-like behaviors, with a lower proportion of resilient individuals compared to males. These findings suggest that, in genetically diverse rats with extended drug access, escalation of intake, continued use despite adverse consequences, and PR responding are highly correlated measures of a shared underlying construct. Furthermore, our results highlight sex differences in resilience to addiction-like behaviors.</p>
</abstract>
<custom-meta-group>
<custom-meta specific-use="meta-only">
<meta-name>publishing-route</meta-name>
<meta-value>prc</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
<notes>
<notes notes-type="competing-interest-statement">
<title>Competing Interest Statement</title><p>The authors have declared no competing interest.</p></notes>
<fn-group content-type="summary-of-updates">
<title>Summary of Updates:</title>
<fn fn-type="update"><p>Updated discussion, New data analysis, New supplementary figures</p></fn>
</fn-group>
</notes>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>Cocaine use disorder remains a serious public health problem in the USA, with 2.2 million regular cocaine users in 2019 and over a million individuals with cocaine use disorder in the past year (<xref ref-type="bibr" rid="c51">SAMHSA, 2019</xref>). The use of cocaine is associated with substantial morbidity and elevated rates of healthcare utilization (<xref ref-type="bibr" rid="c12">Butler et al., 2017</xref>), and over the last 10 years, the number of cocaine-related deaths has quadrupled (<xref ref-type="bibr" rid="c34">Hedegaard et al., 2018</xref>). A key unanswered question for addiction research remains why casual patterns of drug consumption escalate to problematic patterns associated with high motivation and a compulsive-like pattern of drug use in some individuals, but not others and how sex may affect this trajectory (<xref ref-type="bibr" rid="c28">George and Koob, 2017</xref>; <xref ref-type="bibr" rid="c48">Piazza and Deroche-Gamonet, 2013</xref>). Although addiction affects both males and females, most preclinical studies have focused on males (<xref ref-type="bibr" rid="c9">Beery and Zucker, 2011</xref>; <xref ref-type="bibr" rid="c54">Shansky and Murphy, 2021</xref>). Even in studies that use males and females, low sample size often makes it difficult to draw reliable conclusions about the role of sex differences in addiction vulnerability (<xref ref-type="bibr" rid="c8">Becker and Koob, 2016</xref>; <xref ref-type="bibr" rid="c15">Carroll and Lynch, 2016</xref>). To investigate the critical questions about how sex and individual differences interact to produce the vulnerability to develop addiction-like large sample sizes are urgently needed.</p>
<p>Recently, the preclinical addiction field has moved from recognizing “compulsive drug seeking/use” and “continued seeking/use despite negative consequences” as two distinct aspects of addiction, to examining compulsive-like behavior nearly exclusively by models of continued seeking/use despite negative consequences (<xref ref-type="bibr" rid="c16">Chen et al., 2013</xref>; <xref ref-type="bibr" rid="c22">Domi et al., 2021</xref>; <xref ref-type="bibr" rid="c55">Siciliano et al., 2019</xref>; <xref ref-type="bibr" rid="c60">Timme et al., 2022</xref>). The three most prevalent behavioral measures used in animal models of addiction are escalation of drug intake, increased motivation under a progressive ratio (PR) schedule of reinforcement, and continued drug use despite adverse consequences, such as a footshock. These measures are thought to capture different aspects of addiction-like behaviors. Some researchers argue that continued drug use despite adverse consequences is the most critical measure for identifying an addiction phenotype, as it reflects the compulsive nature of drug use (<xref ref-type="bibr" rid="c20">Deroche-Gamonet et al., 2004</xref>; <xref ref-type="bibr" rid="c62">Vanderschuren and Everitt, 2004</xref>). This view is supported by findings that responding despite adverse consequences is sometimes uncorrelated with drug taking/seeking (<xref ref-type="bibr" rid="c10">Belin et al., 2008</xref>; <xref ref-type="bibr" rid="c16">Chen et al., 2013</xref>; <xref ref-type="bibr" rid="c22">Domi et al., 2021</xref>; <xref ref-type="bibr" rid="c46">Pelloux et al., 2007</xref>; <xref ref-type="bibr" rid="c55">Siciliano et al., 2019</xref>; <xref ref-type="bibr" rid="c60">Timme et al., 2022</xref>), suggesting that it may measure a distinct psychological construct. Unfortunately, most of these studies have used low sample size and used animal models with limited access to the drug that are often not associated with significant levels of intoxication or dependence, making it difficult to draw definitive conclusions.</p>
<p>To address these issues, we analyzed addiction-like behaviors in &gt;500 male and female rats that were phenotyped for an ongoing gene-wide association study. We used heterogeneous stock (HS) rats because they are the most highly recombinant rat intercross available and exhibit remarkable individual differences in addiction-like behaviors (<xref ref-type="bibr" rid="c13">Carrette et al., 2021</xref>; <xref ref-type="bibr" rid="c14">Carrette et al., 2022</xref>; <xref ref-type="bibr" rid="c17">Chitre et al., 2020</xref>; <xref ref-type="bibr" rid="c23">Duttke et al., 2022</xref>; <xref ref-type="bibr" rid="c36">Kallupi et al., 2020</xref>; <xref ref-type="bibr" rid="c53">Sedighim et al., 2021</xref>; <xref ref-type="bibr" rid="c56">Solberg Woods and Palmer, 2019</xref>). HS rats were created by interbreeding eight inbred strains and maintaining them as an outbred population in a way that minimizes inbreeding, thereby maximizing genetic diversity within the colony (<xref ref-type="bibr" rid="c56">Solberg Woods and Palmer, 2019</xref>). We used extended access to intravenous cocaine self-administration and characterized escalation of cocaine intake, breaking point under a progressive ratio-schedule of reinforcement, continued use despite adverse consequences (footshock), and irritability-like behavior as a measure of negative affective state during withdrawal.</p>
</sec>
<sec id="s2">
<title>Methods</title>
<p>Detailed procedures associated with the experimental timeline in <xref rid="fig1" ref-type="fig">Fig. 1A</xref> can be found in the George lab protocol repository on protocols.io (<ext-link ext-link-type="uri" xlink:href="https://www.protocols.io/workspaces/george-lab">https://www.protocols.io/workspaces/george-lab</ext-link>).</p>
<fig id="fig1" position="float" orientation="portrait" fig-type="figure">
<label>Figure 1.</label>
<caption><title>Individual differences in addiction-behaviors in HS rats following intravenous cocaine self-administration.</title>
<p>A) Timeline of the behavioral paradigms. B) Number of cocaine infusions in the first hour of cocaine self-administration during short (2 h, ShA) and long (6 h, LgA) access (N=567, *** p &lt; 0.0001 vs the first LgA session). C) Average number of daily infusions for the last 3 days of LgA (N=567). D) Violin plot of number of cocaine infusions under progressive ratio (PR) tested after ShA (1) and LgA, before (2) and after (3) the Shock session (N= 560, *** p &lt; 0.0001). E) Number of infusions despite footshock after LgA compared to a 1 h preshock session (N=466, *** p &lt; 0.0001). F) Correlation of responding during the shock and preschock session is reproduced in each of 10 color coded cohorts (N=466, p &lt; 0.0001). G) Difference in irritability scores after LgA and at baseline (N=380 + 49 naive, behavior *** p &lt; 0.0001, ** p &lt; 0.001 vs naive) H) Principal component analysis of cocaine infusions over all sessions ShA1-10, LgA1-14, PR1-3, Shock with escalation, motivation, and compulsivity indices.</p></caption>
<graphic xlink:href="453410v4_fig1.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
<sec id="s2a">
<title>Animals</title>
<p>HS rats (Rat Genome Database NMcwiWFsm:HS #13673907, sometimes referred to as N/NIH:HS) were created to encompass genetic diversity by outbreeding eight inbred rat strains (ACI/N, BN/SsN, BUF/N, F344/N, M520/N, MR/N, WKY/N and WN/N) in 1984 (<xref ref-type="bibr" rid="c33">Hansen and Spuhler, 1984</xref>; <xref ref-type="bibr" rid="c56">Solberg Woods and Palmer, 2019</xref>). HS rats were bred at Wake Forest University School of Medicine by Dr. Leah Solberg Woods (<italic>n</italic> = 600). To minimize inbreeding and control genetic drift, each generation of the HS rat colony consists of at least 64 breeder pairs and is maintained using a breeding strategy that minimizes inbreeding, with each breeder pair contributing one male and one female to subsequent generations. Each rat received a chip with an RFID code that was used to track animals throughout the experiment. Rats were shipped at 3-4 weeks of age, kept in quarantine for 2 weeks and then housed two per cage on a 12 h/12 h reversed light/dark cycle in a temperature (20-22°C) and humidity (45-55%) controlled vivarium with ad libitum access to tap water and food pellets (PJ Noyes Company, Lancaster, NH, USA). Animals were tested in 12 cohorts of 46-60 rats per cohort, 6 cohorts at The Scripps Research Institute and 6 cohorts at UC San Diego. All procedures were conducted in strict adherence to the National Institutes of Health Guide for the Care and Use of Laboratory Animals and were approved by the Institutional Animal Care and Use Committees of The Scripps Research Institute and UC San Diego.</p>
</sec>
<sec id="s2b">
<title>Drugs</title>
<p>Cocaine HCl (National Institute on Drug Abuse, Bethesda, MD) was dissolved in 0.9% sterile saline and administered intravenously at a dose of 0.5 mg/kg/infusion. This dose was selected based on our and others previous literature demonstrating that this dose is commonly used in rat self-administration studies and is effective in producing addiction-like behaviors (de Guglielmo et al. 2017, Kallupi et al. 2022, Kononoff et al. 2018, <xref ref-type="bibr" rid="c53">Sedighim et al. 2021</xref>, Ahmed and Koob, 1998; <xref ref-type="bibr" rid="c20">Deroche-Gamonet et al., 2004</xref>; Belin et al., 2009). This dose has been shown to maintain stable responding and induce escalation of intake, motivation, and compulsive-like responding in a significant proportion of animals (Ahmed and Koob, 1998; <xref ref-type="bibr" rid="c20">Deroche-Gamonet et al., 2004</xref>; Belin et al., 2009). To ensure consistent dosing, animals were weighed weekly to adjust the drug solution concentration, rounded to the nearest ten grams.</p>
</sec>
<sec id="s2c">
<title>Intravenous Catheterization</title>
<p>Rats were anesthetized with vaporized Isoflurane (1-5%). Intravenous catheters were aseptically inserted into the right jugular vein using the procedure described previously (<xref ref-type="bibr" rid="c36">Kallupi et al., 2020</xref>). Catheters consisted of Micro-Renathane tubing (18 cm, 0.023-inch inner diameter, 0.037-inch outer diameter; Braintree Scientific, Braintree, MA, USA) attached to a 90-degree angle bend guide cannula (Plastics One, Roanoke, VA, USA), embedded in dental acrylic, and anchored with mesh (1 mm thick, 2 cm diameter). Tubing was inserted into the vein following a needle puncture (22 G) and secured with a suture. The guide cannula was punctured through a small incision on the back. The outside part of the cannula was closed off with a plastic seal and metal cover cap, which allowed for sterility and protection of the catheter base. Flunixin (2.5 mg/kg, s.c.) was administered as analgesic, and Cefazolin (330 mg/kg, i.m.) as antibiotic. Rats were allowed three days for recovery prior to any self-administration. They were monitored and flushed daily with heparinized saline (10 U/ml of heparin sodium; American Pharmaceutical Partners, Schaumberg, IL, USA) in 0.9% bacteriostatic sodium chloride (Hospira, Lake Forest, IL, USA) that contained 52.4 mg/0.2 ml of Cefazolin. Catheter patency was tested throughout and at the end of LgA sessions using a short-acting anesthetic (Brevital), any animal that failed to react to the Brevital infusion was excluded from the study.</p>
</sec>
<sec id="s2d">
<title>Behavioral Testing</title>
<sec id="s2d1">
<title>Operant self-administration</title>
<p>Self-administration (SA) was performed in operant conditioning chambers (29 cm × 24 cm × 19.5 cm; Med Associates, St. Albans, VT, USA) that were enclosed in lit, sound-attenuating, ventilated environmental cubicles. The front door and back wall of the chambers were constructed of transparent plastic, and the other walls were opaque metal. Each chamber was equipped with two retractable levers that were located on the front panel. Each session was initiated by the extension of two retractable levers into the chamber. Cocaine (0.5 mg/kg per infusion) was delivered through plastic catheter tubing that was connected to an infusion pump. The infusion pump was activated by responses on the right (active) lever that were reinforced on fixed ratio (FR) 1 schedule, with the delivery of 0.1 mL of the drug per lever press over 6 s followed by a 20-s timeout period that was signaled by the illumination of a cue light above the active lever, during which active lever presses did not result in additional infusions. Responses on the left inactive lever were recorded but had no scheduled consequences. Fluid delivery and behavioral data recording was controlled by a computer with the MED-PC IV software installed. Initially, rats were trained to self-administer cocaine in 10 short access (ShA) sessions (2 h/day, 5 days/week). At the end of the ShA, phase the animals then underwent 14 extended access (LgA) sessions (6 h/day, 5 days/week) in order to measure escalation of drug intake.</p>
</sec>
<sec id="s2d2">
<title>Progressive Ratio Testing</title>
<p>Rats were tested on a progressive ratio (PR) schedule of reinforcement at the end of each phase (twice after LgA, see <xref rid="fig1" ref-type="fig">Fig. 1</xref> for detailed timeline), in which the response requirements for receiving a single reinforcement increased according to the following 1, 2, 4, 6, 9, 12, 15, 20, 25, 32, 40, 50, 62, 77, 95, 118, 145, 178, …. The breakpoint was defined as the last ratio attained by the rat prior to a 60-min period during which a ratio was not completed, which ended the experiment.</p>
</sec>
<sec id="s2d3">
<title>Compulsive-like responding using contingent foot shock</title>
<p>A 1-h footshock punishment testing was conducted between progressive ratio tests following the same parameters as the cocaine self-administration session. Punishment testing followed the same FR1 20-second timeout reinforcement schedule with contingent footshock (0.3 mA, 0.5 s) paired with 30% of the cocaine infusions. This was compared to a 1-h FR1 20-second timeout reinforcement schedule without footshock the day before, called preshock.</p>
</sec>
<sec id="s2d4">
<title>Irritability-like behavior (Bottle Brush Test)</title>
<p>The bottle brush test consisted of ten 10 s trials with 10 s intertrial intervals in plastic cages (27 cm × 48 cm × 20 cm) with clean bedding. The rats were placed in the back of the cage and a bottle brush was rotated rapidly toward the rat’s whiskers. Both aggressive responses (smelling, biting, boxing, following, and exploring the bottle brush) and defensive responses (escaping, digging, jumping, climbing, defecation, vocalization, and grooming) were recorded by three trained observers in real time. Total aggressive and defensive scores were calculated for each animal based on the average score of the observers. Both aggressive and defensive behaviors were summed to calculate the total irritability score. Irritability-like behavior reflects a composite measure of aggressive <italic>vs.</italic> defensive responses (<xref ref-type="bibr" rid="c37">Kimbrough et al., 2017a</xref>). The test was performed after recovery from surgery (baseline) and in withdrawal 18 h after the last LgA session.</p>
</sec>
</sec>
<sec id="s2e">
<title>Analysis</title>
<sec id="s2e1">
<title>Calculation of the Indices</title>
<p>Z-scores were used to reduce sex and cohort effects and scale the different behavioral paradigm outputs. They were calculated as follows Z = (x-μ)/σ, where x is the raw value, μ is the mean of the cohort per sex, and σ is the standard deviation of the cohort per sex. Z-scores were calculated for the following measures: Escalation index is the Z-score of the average intake of an animal on the last 3 d of LgA; Motivation index is the Z-score of the intake during the PR session after LgA; Compulsivity index is the Z-score of the number of infusions during the session with contingent foot shock; Irritability index is the Z-score of the total irritability score with the baseline scores subtracted. The addiction index (AI) was obtained by averaging the relevant behavioral indexes.</p>
</sec>
<sec id="s2e2">
<title>Statistical Analyses</title>
<p>Data were analyzed using Prism 9.0 software (GraphPad, San Diego, CA, USA) and R Studio. Self-administration data were analyzed using repeated-measures analysis of variance (ANOVA) followed by Bonferroni post-hoc tests when appropriate. For pairwise comparisons, data were analyzed using the Student’s <italic>t</italic>-test. Cohen d effect sizes and 95% confidence intervals were calculated using the R effsize package. Correlations were calculated using Pearson <italic>r</italic> analysis. Principal component analysis (PCA) was performed with prcomp in the stats package, using centering, and scaling. Missing data due to session failure was imputed as the average from the sessions before and after (&lt;2% of data). The data are expressed as mean ± SEM unless otherwise specified. Values of p &lt; 0.05 were considered statistically significant.</p>
</sec>
</sec>
</sec>
<sec id="s3">
<title>Results</title>
<sec id="s3a">
<title>Evaluation of Individual Differences in Addiction-Like Behaviors</title>
<p>We assessed addiction-like behaviors in HS rats self-administering cocaine according to the standardized protocol shown in <xref rid="fig1" ref-type="fig">Figure 1A</xref>. Animals were tested in 12 cohorts of 46-60 rats per cohort. Thirty-four animals were excluded from the analysis because they lost their catheter patency (failed Brevital test) before the end of the behavioral protocol. After catheterization surgery and recovery, the rats were trained to self-administer cocaine in 10 daily 2 h short access (ShA) sessions and then in 14 daily 6 h long access (LgA) sessions. Over the course of the extended access of cocaine self-administration phase, the animals showed an escalation of intake, as measured by the significant increase of cocaine rewards taken per hour from day 3 of LgA onwards vs the first day of LgA (<xref rid="fig1" ref-type="fig">Fig. 1B, F</xref><sub>(566,7358)</sub> = 124.4; p &lt; 0.0001 after one-way ANOVA, followed by Bonferroni post hoc comparisons). Evolution of total intake is given in the supporting material <xref ref-type="fig" rid="figs1">Fig S1A</xref>. The number of cocaine infusions in the last three days of LgA were averaged for each rat in order to compare the levels of cocaine intake at the end of the behavioral protocol in the whole population (<xref rid="fig1" ref-type="fig">Fig. 1C</xref>). The results showed a bimodal distribution with ∼20% of rats maintaining very low levels of intake, defined as &lt;50 infusions per session (that corresponded to ∼8 infusions/h, levels normally achieved during ShA, see <xref rid="fig1" ref-type="fig">Fig 1B</xref>) and 80% of the rats escalating their cocaine intake over the course of the extended access protocol. Motivation for cocaine was tested both after ShA and LgA, using a progressive ratio (PR) test (<xref rid="fig1" ref-type="fig">Fig. 1D</xref>). The number of cocaine infusions significantly increased after extended access to cocaine self-administration, compared to the levels at the end of the short access phase (F<sub>2,1690,</sub> = 135.5; p &lt; 0.0001) with the population following a bimodal distribution. Compulsive-like behavior was tested by pairing the cocaine reward with a foot shock (0.3 mA, 30% contingency). HS rats showed high individual variability in compulsive-like cocaine intake with a general decrease in responding during the shock session compared to the preshock session (t<sub>465</sub>=17.88, p&lt;0.0001). Correlational analysis showed that the lever pressing during the preshock session strongly predicted responding during the shock session. This result was true for the whole population (R=0.58, p&lt;2.2 10<sup>-16</sup>) as well as for each individual cohort (<xref rid="fig1" ref-type="fig">Fig. 1F</xref>). Cocaine-induced withdrawal was assessed by measuring irritability-like behavior using the bottle brush test (<xref ref-type="bibr" rid="c38">Kimbrough et al., 2017b</xref>). Irritability-like behavior was measured at the beginning and at the end of the behavioral paradigm (pre- and post-cocaine, <xref rid="fig1" ref-type="fig">Fig. 1G</xref>) and the differences from baseline were compared to data obtained from age-matched naïve animals. Irritability-like behavior was increased in cocaine rats during withdrawal compared to naïve animals as demonstrated by the increased total irritability score (t<sub>427</sub> = 7.57; p &lt; 0.0001 vs naïve after t-test). When breaking the total irritability score in defensive and aggressive responses, we found that animals with a history of cocaine increased their aggressive (t<sub>427</sub> = 7.82; p &lt; 0.0001 vs naïve after t-test) and defensive behaviors (t<sub>427</sub> = 2.79; p = 0.0069 vs naïve after t-test), compared to their naïve counterparts. Finally, to identify patterns in the multidimensional dataset of addiction-like behaviors, a principal component analysis (PCA) was used (<xref rid="fig1" ref-type="fig">Fig. 1H</xref>). This method allows for the identification of latent variables - principal components - that can account for most of the variance within the data, thus simplifying complex data structures. Three significant findings emerged from this analysis. First, the majority of the variance was accounted by the first two principal components (PC), with PC1 and PC2 explaining 48.6% and 15.7% of the variance respectively. Second, measures related to short-term cocaine intake were orthogonal to those collected during longer access periods, showing a consistent daily shift from primarily loading onto PC1 to gradually loading onto PC2. Third, metrics associated with escalating intake, motivation, and compulsive-like responses (calculated by normalizing the behavioral data into indexes using <italic>Z</italic>-scores) were loaded in the same direction onto PC2.</p>
</sec>
<sec id="s3b">
<title>Sex differences in addiction-like behaviors</title>
<p>Major sex differences were observed with females acquiring cocaine self-administration faster and at higher levels than males under short access condition (2 h/day, <xref rid="fig2" ref-type="fig">Fig. 2A</xref>) and during the extended access (6 h/day, <xref rid="fig2" ref-type="fig">Fig. 2A</xref>). A two-way ANOVA with sex as between factor and sessions as within factor showed a significant effect of sex (F<sub>(1, 565)</sub> = 54.87; p &lt; 0.001), sessions (F<sub>(23, 565)</sub> = 345.3; p &lt; 0.001) and of the interaction sex*sessions (F<sub>(23, 12836)</sub> = 5.542; p &lt; 0.001). The Bonferroni post hoc test demonstrated that females self-administered more cocaine compared to males starting from day 4 onward (p &lt; 0.0001). The Cohen d effect size was negligible at sha1 (0.09 [-0.10; 0.27]), small at lga1 (0.47 [0.31;0.64]), and small at lga14 (0.41 [0.25;0.58]). <xref rid="fig2" ref-type="fig">Figure 2B</xref> shows a bimodal distribution with some rats maintaining very low levels of intake. The group of rats with very low intake was composed mostly of male rats. In the progressive ratio test, the two-way ANOVA with sex as between subjects factor and time as within subjects factor showed a significant effect of sex (F<sub>(1, 558)</sub> = 23.57; p &lt; 0.001), time (F<sub>(1, 558)</sub> = 332.65; p &lt; 0.001) but not a sex*time interaction (F<sub>(1, 558)</sub> = 0.35; p = NS), confirming that motivation for cocaine was increased in both sexes over time from ShA to LgA with a large effect size (Cohen d = 0.86 [0.74;0.98]) and that females had significantly higher motivation for cocaine compared to males with a small effect size (Cohen d = 0.32 [0.20;0.44]) independently from the length of access to cocaine (<xref rid="fig2" ref-type="fig">Fig. 2C</xref>). Similar results with a medium effect size were found for compulsive-like behavior, with females obtaining more infusions despite adverse consequences (t<sub>565</sub> = 7.86; p &lt; 0.0001 after t-test, Cohen d = 0.67 [0.50;0.84]; <xref rid="fig2" ref-type="fig">Fig. 2D</xref>). We did not detect any sex-differences in irritability-like behavior (<xref rid="fig2" ref-type="fig">Fig. 2E</xref>), as demonstrated by the non-significant sex factor in the two-way ANOVA (F<sub>(1, 425)</sub> = 0.78; p = NS, Cohen d = 0.19 [0.00;0.38]). Males and females showed large increases in the total irritability scores, compared to naïve rats, as demonstrated by the significant effect of groups (F<sub>(34, 64)</sub> = 34.64; p &lt; 0.0001, Cohen d = 0.89 [0.59;1.20]). Also when breaking the total irritability score in defensive and aggressive responses, we did not find significant sex effects (sex factor in two-way ANOVA, F<sub>(1,854)</sub> = 0.005; p = NS, Cohen d = 0.09 [0.05;0.22]), but found large increases in the aggressive and defensive irritability scores between both sexes, compared to naives (group factor in two-way ANOVA, F<sub>(1,854)</sub> = 24.48; p &lt; 0.001, Cohen d = 0.54 [0.32;0.75]). These results show that compared to the large effects of drug use, sex differences are present with small (for escalation and motivation, Cohen d ∼ 0.3-0.5) to medium (for compulsive-like behavior, Cohen d ∼ 0.7) effect sizes.</p>
<fig id="fig2" position="float" orientation="portrait" fig-type="figure">
<label>Figure 2.</label>
<caption><title>Sex differences in addiction-like behaviors.</title>
<p>A) Cocaine infusions during short (2h, ShA) and long (6h, LgA) access of cocaine self-administration (N = 275 F and 292 M, <sup>###</sup> p &lt;0.0001 vs males) B) Average number of daily infusions for the last 3 days of LgA in male and female rats. C) Violin plot of number of cocaine infusions under progressive ratio (PR) test after ShA and LgA (N = 273 F and 291 M). D) Number of infusions despite footshock after LgA (N= 275 F and 292 M, <sup>###</sup> p &lt; 0.0001). E) Increase in irritability-like behavior in males and females after LgA compared to naive rats, no significant sex differences were detected (N = 186 F + 194 M + 23 naive F + 26 naive M).</p></caption>
<graphic xlink:href="453410v4_fig2.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
</sec>
<sec id="s3c">
<title>Individual differences in cocaine addiction-like behavior: characterization of resilient and vulnerable rats</title>
<p>While all HS rats acquired cocaine self-administration during the ShA phase, we detected major individual differences in their escalation profile that resulted in a bimodal distribution of cocaine intake. We identified animals that were resilient (∼20% of the entire population, they showed an hourly intake of less than 8 infusions/h, similar to the intake during ShA, <xref rid="fig1" ref-type="fig">Fig 1B-C</xref>) or vulnerable (intake higher than 8 infusions/h) to cocaine addiction-like behaviors (<xref rid="fig3" ref-type="fig">Fig 3A-B</xref>). From the analysis of sex differences above, we expected the Resilient group to contain more males. Indeed, among the resilient animals, there were twice as many males compared to females (N = 122 total with 82 males and 40 females). The amounts in the vulnerable group were almost equal (N = 445 total with 210 males and 235 females). Vulnerable rats took more cocaine as demonstrated by the significant interaction on the two-way ANOVA with groups as between factor and time as within factor (F<sub>(23, 12835)</sub> = 85.02; p &lt; 0.0001). The Bonferroni post hoc showed higher levels of cocaine intake in the vulnerable population starting from ShA day 3. When looking at the escalation patterns in vulnerable and resilient rats, we found that the vulnerable group showed an escalation of cocaine intake (significant groups*day interaction, F<sub>(13, 7344)</sub> = 50.16; p &lt; 0.0001) starting from day 3 of extended access (p &lt; 0.001 vs day 1, after two-way ANOVA followed by Bonferroni post hoc), while the rats in the resilient group did not show escalation of intake over the course of the behavioral paradigm, keeping the same level of cocaine infusions (<xref rid="fig3" ref-type="fig">Fig. 3A</xref>). The Cohen d effect size was negligible at ShA1 (0.00 [-0.22; 0.22]), large at lga1 (0.84 [0.63;1.04]), and large at lga14 (2.97 [2.71;3.24]). Major differences between vulnerable and resilient rats were also observed in the motivation to obtain cocaine (PR, two-way ANOVA, significant group factor F<sub>(1, 558)</sub> = 249.17; p &lt; 0.0001, Cohen d = 1.13 [0.98;1.28] and significant group* day interaction, F<sub>(1, 558)</sub> = 86.97; p &lt; 0.0001 followed by Bonferroni post hoc, <xref rid="fig3" ref-type="fig">Fig 3C</xref>) and in compulsive-like responding (foot shock, t<sub>567</sub> = 8.40 p &lt; 0.001, Cohen d = 0.79 [0.58;0.99]; <xref rid="fig3" ref-type="fig">Fig 3D</xref>), but not in irritability-like behavior (t<sub>378</sub> = 1.17 p = NS, Cohen d = 0.14 [- 0.11;0.39]; <xref rid="fig3" ref-type="fig">Fig 3E</xref>). The difference in escalation of intake correlated with differences in the other addiction-like behaviors (R = 0.6, p &lt; 0.001, for PR and R = 0.37, p &lt; 0.001 for compulsivity), but did not correlate with irritability-like behavior (R = 0.048, p = NS).</p>
<fig id="fig3" position="float" orientation="portrait" fig-type="figure">
<label>Figure 3.</label>
<caption><title>Addiction-like behaviors in resilient and vulnerable HS rats.</title>
<p>A) Number of cocaine infusions during short (2h, ShA) and long (6h, LgA) access of cocaine self-administration in resilient and vulnerable animals (N = 122 resilient and 445 vulnerable, *** p &lt; 0.001 vs LgA day 1, <sup>###</sup> p &lt; 0.0001, <sup>##</sup> p &lt; 0.001 vs resilient). B) Average number of infusions over the last 3 days for the individual animals). C) Number of cocaine infusions under progressive ratio (PR) at the end of ShA and LgA (<sup>###</sup> p &lt; 0.0001 vs resilient). D) Number of infusions despite footshock after LgA (<sup>###</sup> p &lt; 0.0001 vs resilient). E) Irritability scores after LgA (N=79 resilient, 301 vulnerable).</p></caption>
<graphic xlink:href="453410v4_fig3.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
</sec>
<sec id="s3d">
<title>Addiction Index: evaluation of individual differences in addiction-like behaviors</title>
<p>To take advantage of all the behaviors related to compulsive intake and withdrawal and further identify subjects that are consistently vulnerable <italic>vs.</italic> resilient to compulsive cocaine use, each measure was normalized into an index using its <italic>Z</italic>-score <inline-formula><inline-graphic xlink:href="453410v4_inline1.gif" mime-subtype="gif" mimetype="image"/></inline-formula>, where χ is the raw value, μ is the mean of the cohort per sex, and σ is the standard deviation of the cohort per sex. We thus obtained an Escalation Index, Motivation Index, Compulsivity Index, and Irritability Index. <xref rid="fig4" ref-type="fig">Figure 4A-D</xref> shows the z-scores for escalation, motivation, compulsive-like responding, and irritability-like behavior. A PCA incorporating the z-scores of the 4 behavioral measures showed that almost half of the variability (48%) can be explained by a single PC, which identified vulnerable and resilient rats and aligned with the escalation, motivation, and compulsivity z-scores (eigenvalue &gt;1, explaining 48% of variance and to which all three behaviors contributed in a valuable way, <italic>r</italic> = 0.52 to 0.60, coefficients 0.6, 0.6, and 0.5 respectively, <xref rid="fig4" ref-type="fig">Fig. 4E</xref>). No difference was identified between the sexes (<xref ref-type="fig" rid="figs3">Fig. S3</xref>). The irritability z-score was almost exactly perpendicular to it, indicating that there was little to no correlation with the other addiction-like behavioral measures (<italic>r</italic> = 0.008, coefficient 0.1). For this reason, we calculated an Addiction Index, that provides a comprehensive evaluation of compulsive cocaine use, by averaging the Z-scores of the three dependent variables that explain almost 50% of the variance, escalation, motivation, and compulsive-like behavior, leaving out irritability-like behavior (<xref rid="fig4" ref-type="fig">Fig. 4F</xref>).</p>
<fig id="fig4" position="float" orientation="portrait" fig-type="figure">
<label>Figure 4.</label>
<caption><title>Normalizing and combining addiction like behaviors into an addiction index.</title>
<p>A) Z-score for escalation (N=566), B) motivation (N=512), C) compulsivity (N=567) and D) irritability-like behavior (N=380) in the whole population. E) Representation of the individual rats (N=377), resilient (green) or vulnerable (red) along the two first principal components, based on escalation, motivation, compulsivity, and irritability z-scores. F) Representation of the addiction index for the individual rats with the constituting individual z-scores and their identification as resilient or vulnerable and male or female (N=511).</p></caption>
<graphic xlink:href="453410v4_fig4.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
</sec>
<sec id="s3e">
<title>Different degrees of addiction-like behavior</title>
<p>We next used the addiction index to further differentiate between low, mild, moderate, and severe addiction-like behavior in the population, by dividing them into four quartiles. As the indices were derived per sex, quantile normalization resulted in a roughly equal number of males and females in each group: 57 females and 71 males in the Low group, 68 females and 60 males in the Mild group, 67 females and 60 males in the Moderate group, and 57 females and 71 males in the Severe group. The intake in the different groups of rats, divided according to their Addiction Index over the last 3 days of LgA is shown in <xref rid="fig5" ref-type="fig">figures 5</xref> A-B. Cocaine intake was increased from Low over Mild and Moderate to Severe groups. The two-way ANOVA with group as between factor and sessions as within factor showed a significant effect of group (F<sub>(3, 511)</sub> = 91.36; p &lt; 0.0001), sessions (F<sub>(23, 511)</sub> = 329.4; p &lt; 0.0001) and of the interaction group*sessions (F<sub>(69, 11502)</sub> = 18.48; p &lt; 0.0001). Pairwise comparisons for the significant main effects of groups, demonstrated that each of the subgroups (divided based on their Addiction Index) obtained more cocaine than their immediate lower subgroup (Severe &gt; Moderate &gt; Mild &gt; Low, p &lt; 0.0001; <xref rid="fig5" ref-type="fig">Fig 5A</xref>). At LgA14 the effect sizes are large between Low and Mild, Moderate and Severe, and between Mild and Severe (Cohen d = 1.44 [1.17;1.72], 2.31 [1.99;2.63], 2.50 [2.17;2.83], and 0.81 [0.55;1.07], respectively), medium between Mild and Moderate (Cohen d = 0.59 [0.34;0.84]), and small between Moderate and Severe (Cohen d = 0.28 [0.03;053]). In the progressive ratio test (<xref rid="fig5" ref-type="fig">Fig. 5C</xref>), the two-way ANOVA effect of group (F<sub>(3, 504)</sub> = 176.49; p &lt; 0.0001), time (F<sub>(1, 504)</sub> = 423.32; p &lt; 0.0001) and of the interaction group*time (F<sub>(3, 504)</sub> = 52.4; p &lt; 0.0001). This was associated with large effect sizes for the Severe, Moderate, and Mild groups (Cohen d = 1.65 [1.36;1.93], 1.74 [1.45;2.03], and 0.95 [0.69;1.21], respectively), and a negligible effect size in the Low group Cohen d = 0.08 [-0.17;0.32]). Pairwise comparisons showed that the Mild, Moderate, and Severe groups, but not the Low group, showed increased breakpoint after long access, compared to after short access (p &lt; 0.0001 after Bonferroni post hoc). Within each timepoint, the Mild, Moderate, and Severe subgroups showed increased motivation for cocaine to the Low subgroup (p &lt; 0.0001 after Bonferroni post hoc, Cohen d = 0.71 [0.42;0.96], 0.95 [0.69;1.22], and 1.16 [0.89;1.43] for ShA, or 1.57 [1.29;1.85], 3.20 [2.83;3.58], and 3.36 [2.98;3.74] for LgA, respectively; <xref rid="fig5" ref-type="fig">Fig 5C</xref>). For the compulsivity test the one-way ANOVA showed a significant main effect (F<sub>(3, 507)</sub> = 76.6; p &lt; 0.0001) with each of the subgroups showing increased compulsivity compared to their immediate subgroup (p &lt; 0.001 after the Bonferroni post hoc test; <xref rid="fig5" ref-type="fig">Fig. 5D</xref>). The associated effect sizes were medium from Low to Mild (Cohen d = 0.58 [0.33,0.83]), small from Mild to Moderate (Cohen d = 0.45 [0.20,0.70]), and medium from Moderate to Severe (Cohen d = 0.72 [0.47,0.98]); with a large effect size between Low and Severe (Cohen d = 2.08 [1.77,2.38]). These results demonstrate the variability in the addiction-like behaviors between the individuals, resulting in large effect sizes when comparing the two extreme quartiles Low and Severe (Cohen d ∼2.5-3.5).</p>
<fig id="fig5" position="float" orientation="portrait" fig-type="figure">
<label>Figure 5.</label>
<caption><title>Different degrees of vulnerability to cocaine addictive behaviors.</title>
<p>A) Cocaine infusions during short (2h, ShA) and long (6h, LgA) access of cocaine self-administration (N = 128 Low + 128 Mild + 127 Moderate + 128 Severe; *** p &lt;0.0001). B) Average number of cocaine infusions over the last 3 days for the individual animals in the low, mild moderate and severe vulnerable groups. C) Number of cocaine infusions under progressive ratio (PR) test at the end of the ShA and LgA phases (*** p &lt; 0.0001 vs low, <sup>###</sup> p &lt;0.0001 vs ShA) D) Number of infusions despite footshock after LgA for the resilient and vulnerable groups (** p &lt;0.001 and *** p &lt;0.0001).</p></caption>
<graphic xlink:href="453410v4_fig5.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
</sec>
</sec>
<sec id="s4">
<title>Discussion</title>
<p>We characterized addiction-like behavior in 556 genetically diverse HS rats by establishing a large behavioral screening aimed at studying different cocaine-related behaviors (escalation, motivation, compulsive-like responding, and irritability-like behavior). A bimodal distribution was observed, with ∼20% of rats maintaining low intake levels and ∼80% escalating their cocaine intake when given long access. Females exhibited faster acquisition and higher levels of cocaine self-administration compared to males. Individual differences were found, with some rats categorized as resilient and others as vulnerable to addiction-like behaviors. Vulnerable rats showed an increased escalation of cocaine intake, motivation, and compulsive-like responding. Correlational and principal component analysis revealed that a single construct explained 48% of the behavioral variability, separating vulnerable and resilient rats. This construct included the variables associated with escalation of intake, breaking point under a progressive ratio, and continued responding despite adverse consequences under long access, but not irritability-like measures or self-administration measures under short access. Moreover, responding before the shock session strongly predicted continued responding despite adverse consequences during the shock session. The use of an Addiction Index calculated based on the escalation of intake, breaking point under a progressive ratio, and continued responding despite adverse consequences allows to further identify different levels of severity of addiction-like behaviors from animals exhibiting resilience, low, moderate, and severe addiction-like behaviors.</p>
<p>The high throughput behavioral paradigm used a model of extended access to intravenous self-administration combined with behavioral characterization of compulsivity using progressive ratio responding and responding despite adverse consequences (contingent foot shocks). We chose the model of extended access to cocaine self-administration because it is highly relevant to cocaine use disorder (<xref ref-type="bibr" rid="c24">Edwards and Koob, 2013</xref>; <xref ref-type="bibr" rid="c29">George et al., 2014</xref>), and is associated with neuroadaptations that are also observed in humans with cocaine use disorder (<xref ref-type="bibr" rid="c1">Adinoff et al., 1990</xref>; <xref ref-type="bibr" rid="c11">Briand et al., 2008</xref>; <xref ref-type="bibr" rid="c30">George et al., 2008</xref>; <xref ref-type="bibr" rid="c31">George et al., 2012</xref>; <xref ref-type="bibr" rid="c64">Vendruscolo et al., 2012</xref>). After escalation, intake was bimodally distributed. While ∼80% of rats (vulnerable) escalated their cocaine intake after being given long access to cocaine, ∼ 20% of rats (resilient) maintained a low and stable level of cocaine intake. The low and stable level of intake in resilient rats was not due to lack of catheter patency or failure to self-administer a reward (<xref ref-type="bibr" rid="c53">Sedighim et al., 2021</xref>). It is important to note that while our study focused on the differences between resilient and vulnerable rats under long access conditions, the short access period may also be predictive of addiction-like behaviors, particularly in genetically diverse populations. The observed escalation of drug intake during short access in our study is not due to an acquisition issue, as rats start differentiating the active from the inactive levers on the first day of ShA1 (<xref ref-type="fig" rid="figs1">Fig. S1B</xref>), with a 3 to 1 ratio between active/inactive pressing by ShA7. Rather, this early escalation in some individuals could be due to the genetic diversity of the HS rat population, which includes 8 different strains as founder parents. Previous studies have shown profound strain differences in vulnerability to cocaine self-administration and escalation of intake (<xref ref-type="bibr" rid="c26">Freeman et al., 2009</xref>; <xref ref-type="bibr" rid="c41">Kosten et al., 2007</xref>; <xref ref-type="bibr" rid="c47">Perry et al., 2006</xref>; <xref ref-type="bibr" rid="c49">Picetti et al., 2010</xref>; <xref ref-type="bibr" rid="c61">Valenza et al., 2016</xref>). Additionally, our use of a 2-hour short access period, compared to the more common 1-hour period, may have allowed for the detection of these individual differences that might otherwise be masked by a ceiling effect in shorter sessions.</p>
<p>The identified resilient group was enriched for males, as over 2/3 of the resilient animals were male. Moreover, we found that females not only showed a low percentage of resilient animals but also showed higher levels of cocaine intake, motivation, and aversion resistance than males in rats with moderate and severe addiction-like behaviors. The increased motivation and compulsive-like responses in females cannot simply be explained by the higher intake among females, as the significant difference remained when we compared only the vulnerable rats in both sexes (see <xref ref-type="fig" rid="figs2">Fig. S2</xref>). Previous preclinical studies have reported mixed results on the detection of sex differences in addiction (<xref ref-type="bibr" rid="c3">Algallal et al., 2020</xref>; <xref ref-type="bibr" rid="c7">Becker, 2016</xref>; <xref ref-type="bibr" rid="c50">Roth and Carroll, 2004</xref>; <xref ref-type="bibr" rid="c58">Swalve et al., 2016</xref>; <xref ref-type="bibr" rid="c59">Templeton et al., 2023</xref>). In humans, cocaine use disorder is more prevalent in males than in females (<xref ref-type="bibr" rid="c51">SAMHSA, 2019</xref>), but this might be driven by societal factors. Women may actually be more vulnerable to the reinforcing effects of cocaine and acquire cocaine use disorder faster and at higher levels than males (<xref ref-type="bibr" rid="c19">Cummings et al., 2011</xref>; <xref ref-type="bibr" rid="c35">Jackson et al., 2006</xref>). Sex differences were found in HS rats for cocaine cue preference (<xref ref-type="bibr" rid="c39">King et al., 2021</xref>). The current study was able to replicate the presence of sex differences in cocaine addiction-like behaviors in this large and diverse population with small to moderate effect sizes. The smaller effect size of sex differences, compared to the large effect of drug intake, could explain the contradictory results in the field from underpowered studies. Indeed, a statistical power analysis using every significant sex difference observed in our study shows that studies would require 34 – 100 animals to find significant sex effects at alpha = 0.05 with 80% power; unfortunately, such sample sizes are rarely used in the field.</p>
<p>To further investigate potential sex differences in the behavioral constructs underlying addiction-like behaviors, we first examined male vs. female differences in the biplot represented in <xref rid="fig4" ref-type="fig">Fig. 4E</xref>, which included the irritability index. This analysis, shown in supplemental <xref ref-type="fig" rid="figs3">Figure S3B</xref>, revealed no apparent sex differences in the overall structure of addiction-like behaviors. However, when we performed separate PCAs for males and females (<xref ref-type="fig" rid="figs3">Figure S3 C, D</xref>), we found that the relationship between the Compulsivity Index and the other addiction-like behaviors differed between sexes. In males, compulsivity was more positively correlated with irritability, while in females, the relationship was opposite (<xref ref-type="fig" rid="figs3">Figure S3 C, D</xref>). However, when the irritability index was excluded from the analysis, the resulting PCA plots for males and females were almost identical (<xref ref-type="fig" rid="figs3">Figure S3 E, F</xref>). These findings suggest that sex differences in the relationship between compulsivity and other addiction-like behaviors may be driven, in part, by differences in irritability. This observation highlights the importance of considering sex-specific patterns when investigating the complex relationships between different aspects of addiction-like behavior Withdrawal-induced irritability-like behavior was increased in rats with a history of cocaine self-administration compared to naïve aged-matched rats. This result is in line with previous evidence of a negative emotional state in the long-access model (<xref ref-type="bibr" rid="c2">Ahmed and Koob, 2005</xref>; <xref ref-type="bibr" rid="c20">Deroche-Gamonet et al., 2004</xref>; <xref ref-type="bibr" rid="c43">Mantsch et al., 2004</xref>). However, this increase in irritability-like behavior did not correlate with any self-administration measures and was orthogonal to them in the PCA. Animals taking more cocaine were not typically the ones that were more irritable, suggesting that irritability may not be a direct measure of withdrawal severity. Similarly, more irritable animals did not necessarily take more cocaine, indicating that irritability may not be a strong driver of escalation in this model, although it may contribute to relapse and craving. The identified increased negative emotional state may thus be independent, capturing a different aspect of addiction or be due to non-specific effects associated with the protocol, including surgery, chronic catheter implant, and daily testing for approximately 2 months.</p>
<p>Despite the lack of correlation between irritability-like behavior and drug intake in our study, it is important to consider the translational relevance of irritability in the context of substance use disorders. In individuals with a history of substance use disorder, negative affective states, such as irritability, are thought to contribute to continued drug use and relapse through negative reinforcement processes (<xref ref-type="bibr" rid="c5">Baker et al., 2004</xref>; <xref ref-type="bibr" rid="c40">Koob and Le Moal, 2008</xref>). Specifically, the desire to alleviate or escape from these unwanted behavioral states may drive individuals to seek and use drugs, thus perpetuating the cycle of addiction (<xref ref-type="bibr" rid="c5">Baker et al., 2004</xref>; <xref ref-type="bibr" rid="c57">Solomon and Corbit, 1974</xref>). While our study focused on the relationship between irritability-like behavior and initial drug-seeking behavior, future research should investigate the degree to which irritability acts as a negative reinforcer in the context of drug relapse.</p>
<p>For the purpose of the addiction index, the irritability-like behavior measure was excluded to capture and maximize the diversity associated with PC1’s cocaine intake following escalation under progressive ratio and despite aversive footshock. This decision was based on the lack of correlation between irritability and drug intake measures. It is important to note that for the PCA presented in <xref rid="fig4" ref-type="fig">Figure 4E</xref>, we carefully selected only four key variables: the Z-scores for escalation (average intake at the end of LgA), motivation (intake under progressive ratio), compulsivity (continued responding despite adverse consequences), and irritability. This approach minimized variable redundancy and focused on essential measures of addiction-like behaviors. Furthermore, to ensure the robustness of our findings, we conducted an additional PCA excluding the irritability index, using only the escalation, motivation, and compulsivity indices for the same 377 animals. The results of this analysis (<xref ref-type="fig" rid="figs3">Figure S3A</xref>) corroborated our original findings, with these three variables loading onto a single factor that explained a significant portion of the variance in addiction-like behaviors. However, further studies are needed to differentiate between the possibilities that the increased negative emotional state may be an independent aspect of addiction or due to non-specific effects associated with the protocol, and to investigate the specific role of irritability-like behavior in the context of cocaine use disorder.</p>
<p>Addiction is commonly described as a chronic, recurring condition characterized by excessive drug consumption, compulsive drug seeking, and continued drug use despite negative consequences (<xref ref-type="bibr" rid="c51">SAMHSA, 2019</xref>). There is a prevailing notion in preclinical addiction research that the only way to identify addiction-like behaviors in individuals is by measuring compulsive drug use and seeking using continued responding despite adverse consequences. Continued drug use or seeking in the face of punishment, such as painful footshocks or aversive tastes, is widely considered the behavioral hallmark of compulsive-like drug-seeking behavior in preclinical models (<xref ref-type="bibr" rid="c16">Chen et al., 2013</xref>; <xref ref-type="bibr" rid="c22">Domi et al., 2021</xref>; <xref ref-type="bibr" rid="c32">Giuliano et al., 2019</xref>; <xref ref-type="bibr" rid="c42">Li et al., 2021</xref>; <xref ref-type="bibr" rid="c55">Siciliano et al., 2019</xref>; <xref ref-type="bibr" rid="c60">Timme et al., 2022</xref>). A key argument in favor of this hypothesis is that several studies have found that drug intake in the absence of an adverse consequence does not predict drug intake in the presence of an adverse consequence, suggesting that they are independent behavioral measures and that only measures of drug taking/seeking in the context of punishment can measure compulsive-like drug taking/seeking (<xref ref-type="bibr" rid="c16">Chen et al., 2013</xref>; <xref ref-type="bibr" rid="c22">Domi et al., 2021</xref>; <xref ref-type="bibr" rid="c32">Giuliano et al., 2019</xref>; <xref ref-type="bibr" rid="c42">Li et al., 2021</xref>; <xref ref-type="bibr" rid="c55">Siciliano et al., 2019</xref>; <xref ref-type="bibr" rid="c60">Timme et al., 2022</xref>). However, the results from the present report provide strong evidence that in heterogeneous outbred rats, continued responding despite adverse consequences is not an independent measure of compulsive-like responding that is orthogonal to other measures such as escalation of intake and motivation under a progressive ratio schedule of reinforcement. Both correlational and principal component analyses demonstrate that these three behaviors are highly correlated and load onto the same underlying construct.</p>
<p>It is important to consider that the observed correlations between escalation of intake, increased motivation under progressive ratio, and responding despite negative consequences may be influenced by individual differences in baseline response rates. Previous research has shown that animals with higher baseline rates of responding tend to be less sensitive to punishment and exhibit higher levels of responding under progressive ratio schedules (<xref ref-type="bibr" rid="c21">Dews, 1955</xref>; <xref ref-type="bibr" rid="c52">Sanger and Blackman, 1976</xref>). While our findings suggest that these behaviors can be explained by a single psychological construct related to addiction vulnerability, we cannot rule out the possibility that individual differences in baseline response rates may contribute to the observed correlations. Future studies should investigate the relationship between baseline response rates and addiction-like behaviors to further clarify the underlying mechanisms.</p>
<p>A possible explanation as to why previous studies failed to observe this correlation between escalation, motivation, and aversion-resistance is that most of the previous studies used small sample sizes that may not provide sufficient statistical power to observe this relationship between variables. Another explanation is that previous studies often used animal models with limited access to the drug, where animals exhibit low levels of acute intoxication and very little, if any, signs of drug dependence (<xref ref-type="bibr" rid="c27">George et al., 2022</xref>). However, it is important to note that several behavioral and pharmacological studies have indicated that different measures may capture, at least to some degree, different aspects of addiction-like behavior in alcohol and opioid-dependent rodents (<xref ref-type="bibr" rid="c4">Aoun et al., 2018</xref>; <xref ref-type="bibr" rid="c6">Barbier et al., 2015</xref>; <xref ref-type="bibr" rid="c45">Marchette et al., 2023</xref>). While the present results suggest that escalation of drug intake highly predicts drug responding despite adverse consequences in an animal model with long access to cocaine and evidence of drug dependence, further research is needed to determine the extent to which these findings generalize to other drugs of abuse and different stages of the addiction cycle.</p>
<p>It is important to acknowledge that several experimental factors could influence the outcomes of the PCA analysis. These factors include the schedule of reinforcement, the progression of the progressive ratio schedule, the shock intensity, the contingency of the shock, the cocaine unit dose, and the use of multiple punishment sessions (<xref ref-type="bibr" rid="c10">Belin et al., 2008</xref>; <xref ref-type="bibr" rid="c20">Deroche-Gamonet et al., 2004</xref>; <xref ref-type="bibr" rid="c46">Pelloux et al., 2007</xref>). In particular, learning effects may play a role when animals undergo multiple punishment or progressive ratio sessions. An animal’s response to punishment or its performance in progressive ratio sessions may change over time as it learns from its previous experiences (<xref ref-type="bibr" rid="c44">Marchant et al., 2013</xref>; <xref ref-type="bibr" rid="c63">Vanderschuren et al., 2017</xref>). While the present study utilized a large dataset obtained from a particular experimental design, it is essential to acknowledge that not finding differences in one dataset does not necessarily mean that these differences do not exist. Future studies should investigate the impact of these experimental factors, including learning effects, on the relationship between escalation, motivation, and aversion-resistance to further elucidate the underlying constructs of addiction-like behaviors.</p>
<p>Finally, this report demonstrates the feasibility of characterizing a very large population of heterogeneous rats for addiction-like behavior using an animal model of extended access of intravenous drug self-administration. Such a large-scale behavioral approach is required to unveil differences with smaller effect sizes like sex differences and the genetic basis of addiction-like behavior. The evaluation of different addiction-like behaviors is important, as previous research has suggested that multiple elements of addiction vulnerability may be independently heritable (<xref ref-type="bibr" rid="c25">Eid et al., 2019</xref>). While our current findings indicate that escalation, motivation, and compulsivity are highly correlated and load onto a single construct in our model, it is possible that distinct genes contribute to different aspects of addiction vulnerability. The high correlation between these behaviors in our study may reflect common underlying genetic influences, but it does not preclude the existence of additional, unique genetic factors that shape specific aspects of addiction-like behavior. Further research is needed to identify the specific genes that contribute to the overall construct of addiction vulnerability, as well as those that may influence distinct behavioral elements. The behavioral characterization of HS rats in this study provides a foundation for future genome-wide association studies (GWAS) aimed at identifying specific alleles and genes that contribute to vulnerability and resilience to cocaine addiction-like behavior (<xref ref-type="bibr" rid="c17">Chitre et al., 2020</xref>). Moreover, biological samples from animals that are resilient or have mild, moderate, or severe addiction-like behaviors are currently available through the Cocaine Biobank (<ext-link ext-link-type="uri" xlink:href="http://www.cocainebiobank.org">www.cocainebiobank.org</ext-link>) to facilitate collaboration and investigation on the biological mechanisms of addiction-like behaviors (<xref ref-type="bibr" rid="c13">Carrette et al., 2021</xref>).</p>
<p>In summary, this study examined addiction-like behaviors in a large population of genetically diverse male and female rats. We found that ∼80% of the rats were vulnerable and escalated their cocaine intake, while ∼20% was resilient and maintained low stable levels. The resilient group had two times more males than females. Females also had higher susceptibility to cocaine self-administration than males, both qualitatively and quantitively. Correlational and principal component analyses showed that escalation of intake, aversion-resistant responding, and breaking points are highly correlated measures of the same construct in animals with extended access to the drug. This study provides in-depth characterization of heterogeneous rats with a variety of addiction-like profiles from resilience to mild, moderate, and severe addiction-like behaviors that can be used to investigate the biological mechanisms of addiction.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgements</title>
<p>This work was supported by National Institutes of Health grant U01DA043799 and P50DA037844 from the National Institute on Drug Abuse and funding from the Preclinical Addiction Research Consortium at UCSD. The authors declare no competing financial interests.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="c1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Adinoff</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Martin</surname>, <given-names>P. R.</given-names></string-name>, <string-name><surname>Bone</surname>, <given-names>G. H.</given-names></string-name>, <string-name><surname>Eckardt</surname>, <given-names>M. J.</given-names></string-name>, <string-name><surname>Roehrich</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>George</surname>, <given-names>D. T.</given-names></string-name>, <string-name><surname>Moss</surname>, <given-names>H. B.</given-names></string-name>, <string-name><surname>Eskay</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Linnoila</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Gold</surname>, <given-names>P. W</given-names></string-name></person-group>., <year>1990</year>. <article-title>Hypothalamic-pituitary-adrenal axis functioning and cerebrospinal fluid corticotropin releasing hormone and corticotropin levels in alcoholics after recent and long-term abstinence</article-title>. <source>Arch Gen Psychiatry</source> <volume>47</volume>, <fpage>325</fpage>–<lpage>330</lpage>.</mixed-citation></ref>
<ref id="c2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ahmed</surname>, <given-names>S. H.</given-names></string-name>, <string-name><surname>Koob</surname>, <given-names>G. F</given-names></string-name></person-group>., <year>2005</year>. <article-title>Transition to drug addiction: a negative reinforcement model based on an allostatic decrease in reward function</article-title>. <source>Psychopharmacology (Berl</source>) <volume>180</volume>, <fpage>473</fpage>–<lpage>490</lpage>.</mixed-citation></ref>
<ref id="c3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Algallal</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Allain</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Ndiaye</surname>, <given-names>N. A.</given-names></string-name>, <string-name><surname>Samaha</surname>, <given-names>A.-N</given-names></string-name></person-group>., <year>2020</year>. <article-title>Sex differences in cocaine self-administration behaviour under long access versus intermittent access conditions</article-title>. <source>Addiction Biology</source> <volume>25</volume>, <fpage>e12809</fpage>.</mixed-citation></ref>
<ref id="c4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Aoun</surname>, <given-names>E. G.</given-names></string-name>, <string-name><surname>Jimenez</surname>, <given-names>V. A.</given-names></string-name>, <string-name><surname>Vendruscolo</surname>, <given-names>L. F.</given-names></string-name>, <string-name><surname>Walter</surname>, <given-names>N. A. R.</given-names></string-name>, <string-name><surname>Barbier</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Ferrulli</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Haass-Koffler</surname>, <given-names>C. L.</given-names></string-name>, <string-name><surname>Darakjian</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Lee</surname>, <given-names>M. R.</given-names></string-name>, <string-name><surname>Addolorato</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Heilig</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Hitzemann</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Koob</surname>, <given-names>G. F.</given-names></string-name>, <string-name><surname>Grant</surname>, <given-names>K. A.</given-names></string-name>, <string-name><surname>Leggio</surname>, <given-names>L</given-names></string-name></person-group>., <year>2018</year>. <article-title>A relationship between the aldosterone-mineralocorticoid receptor pathway and alcohol drinking: preliminary translational findings across rats, monkeys and humans</article-title>. <source>Mol Psychiatry</source> <volume>23</volume>, <fpage>1466</fpage>–<lpage>1473</lpage>.</mixed-citation></ref>
<ref id="c5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Baker</surname>, <given-names>T. B.</given-names></string-name>, <string-name><surname>Piper</surname>, <given-names>M. E.</given-names></string-name>, <string-name><surname>McCarthy</surname>, <given-names>D. E.</given-names></string-name>, <string-name><surname>Majeskie</surname>, <given-names>M. R.</given-names></string-name>, <string-name><surname>Fiore</surname>, <given-names>M. C</given-names></string-name></person-group>., <year>2004</year>. <article-title>Addiction motivation reformulated: an affective processing model of negative reinforcement</article-title>. <source>Psychol Rev</source> <volume>111</volume>, <fpage>33</fpage>–<lpage>51</lpage>.</mixed-citation></ref>
<ref id="c6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Barbier</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Tapocik</surname>, <given-names>J. D.</given-names></string-name>, <string-name><surname>Juergens</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Pitcairn</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Borich</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Schank</surname>, <given-names>J. R.</given-names></string-name>, <string-name><surname>Sun</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Schuebel</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Zhou</surname>, <given-names>Z.</given-names></string-name>, <string-name><surname>Yuan</surname>, <given-names>Q.</given-names></string-name>, <string-name><surname>Vendruscolo</surname>, <given-names>L. F.</given-names></string-name>, <string-name><surname>Goldman</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Heilig</surname>, <given-names>M</given-names></string-name></person-group>., <year>2015</year>. <article-title>DNA methylation in the medial prefrontal cortex regulates alcohol-induced behavior and plasticity</article-title>. <source>J Neurosci</source> <volume>35</volume>, <fpage>6153</fpage>–<lpage>6164</lpage>.</mixed-citation></ref>
<ref id="c7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Becker</surname>, <given-names>J. B</given-names></string-name></person-group>., <year>2016</year>. <article-title>Sex differences in addiction</article-title>. <source>Dialogues in Clinical Neuroscience</source> <volume>18</volume>, <fpage>395</fpage>–<lpage>402</lpage>.</mixed-citation></ref>
<ref id="c8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Becker</surname>, <given-names>J. B.</given-names></string-name>, <string-name><surname>Koob</surname>, <given-names>G. F</given-names></string-name></person-group>., <year>2016</year>. <article-title>Sex Differences in Animal Models: Focus on Addiction</article-title>. <source>Pharmacol Rev</source> <volume>68</volume>, <fpage>242</fpage>–<lpage>263</lpage>.</mixed-citation></ref>
<ref id="c9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Beery</surname>, <given-names>A. K.</given-names></string-name>, <string-name><surname>Zucker</surname>, <given-names>I</given-names></string-name></person-group>., <year>2011</year>. <article-title>Sex bias in neuroscience and biomedical research</article-title>. <source>Neurosci Biobehav Rev</source> <volume>35</volume>, <fpage>565</fpage>–<lpage>572</lpage>.</mixed-citation></ref>
<ref id="c10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Belin</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Mar</surname>, <given-names>A. C.</given-names></string-name>, <string-name><surname>Dalley</surname>, <given-names>J. W.</given-names></string-name>, <string-name><surname>Robbins</surname>, <given-names>T. W.</given-names></string-name>, <string-name><surname>Everitt</surname>, <given-names>B. J</given-names></string-name></person-group>., <year>2008</year>. <article-title>High impulsivity predicts the switch to compulsive cocaine-taking</article-title>. <source>Science</source> <volume>320</volume>, <fpage>1352</fpage>–<lpage>1355</lpage>.</mixed-citation></ref>
<ref id="c11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Briand</surname>, <given-names>L. A.</given-names></string-name>, <string-name><surname>Flagel</surname>, <given-names>S. B.</given-names></string-name>, <string-name><surname>Seeman</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Robinson</surname>, <given-names>T. E</given-names></string-name></person-group>., <year>2008</year>. <article-title>Cocaine self-administration produces a persistent increase in dopamine D2 High receptors</article-title>. <source>Eur Neuropsychopharmacol</source> <volume>18</volume>, <fpage>551</fpage>–<lpage>556</lpage>.</mixed-citation></ref>
<ref id="c12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Butler</surname>, <given-names>A. J.</given-names></string-name>, <string-name><surname>Rehm</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Fischer</surname>, <given-names>B</given-names></string-name></person-group>., <year>2017</year>. <article-title>Health outcomes associated with crack-cocaine use: Systematic review and meta-analyses</article-title>. <source>Drug Alcohol Depend</source> <volume>180</volume>, <fpage>401</fpage>–<lpage>416</lpage>.</mixed-citation></ref>
<ref id="c13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Carrette</surname>, <given-names>L. L.</given-names></string-name>, <string-name><surname>de Guglielmo</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Kallupi</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Maturin</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Brennan</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Boomhower</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Conlisk</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Sedighim</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Tieu</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Fannon</surname>, <given-names>M. J.</given-names></string-name>, <string-name><surname>Velarde</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Kononoff</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Kimbrough</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Simpson</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Smith</surname>, <given-names>L. C.</given-names></string-name>, <string-name><surname>Shankar</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Ramirez</surname>, <given-names>F.</given-names>, <suffix>Jr.</suffix></string-name>, <string-name><surname>Chitre</surname>, <given-names>A. S.</given-names></string-name>, <string-name><surname>Lin</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Polesskaya</surname>, <given-names>O.</given-names></string-name>, <string-name><surname>Solberg Woods</surname>, <given-names>L. C.</given-names></string-name>, <string-name><surname>Palmer</surname>, <given-names>A. A.</given-names></string-name>, <string-name><surname>George</surname>, <given-names>O.</given-names></string-name></person-group>, <year>2021</year>. <article-title>The cocaine and oxycodone biobanks, two repositories from genetically diverse and behaviorally characterized rats for the study of addiction</article-title>. <source>eNeuro</source>.</mixed-citation></ref>
<ref id="c14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Carrette</surname>, <given-names>L. L. G.</given-names></string-name>, <string-name><surname>Corral</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Boomhower</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Brennan</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Crook</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Ortez</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Shankar</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Simpson</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Maturin</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Solberg Woods</surname>, <given-names>L. C.</given-names></string-name>, <string-name><surname>Palmer</surname>, <given-names>A. A.</given-names></string-name>, <string-name><surname>de Guglielmo</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>George</surname>, <given-names>O.</given-names></string-name></person-group>, <year>2022</year>. <article-title>Leptin Protects Against the Development and Expression of Cocaine Addiction-Like Behavior in Heterogeneous Stock Rats</article-title>. <source>Front Behav Neurosci</source> <volume>16</volume>, <fpage>832899</fpage>.</mixed-citation></ref>
<ref id="c15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Carroll</surname>, <given-names>M. E.</given-names></string-name>, <string-name><surname>Lynch</surname>, <given-names>W. J</given-names></string-name></person-group>., <year>2016</year>. <article-title>How to study sex differences in addiction using animal models</article-title>. <source>Addict Biol</source> <volume>21</volume>, <fpage>1007</fpage>–<lpage>1029</lpage>.</mixed-citation></ref>
<ref id="c16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chen</surname>, <given-names>B. T.</given-names></string-name>, <string-name><surname>Yau</surname>, <given-names>H. J.</given-names></string-name>, <string-name><surname>Hatch</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Kusumoto-Yoshida</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Cho</surname>, <given-names>S. L.</given-names></string-name>, <string-name><surname>Hopf</surname>, <given-names>F. W.</given-names></string-name>, <string-name><surname>Bonci</surname>, <given-names>A</given-names></string-name></person-group>., <year>2013</year>. <article-title>Rescuing cocaine-induced prefrontal cortex hypoactivity prevents compulsive cocaine seeking</article-title>. <source>Nature</source> <volume>496</volume>, <fpage>359</fpage>–<lpage>362</lpage>.</mixed-citation></ref>
<ref id="c17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chitre</surname>, <given-names>A. S.</given-names></string-name>, <string-name><surname>Polesskaya</surname>, <given-names>O.</given-names></string-name>, <string-name><surname>Holl</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Gao</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Cheng</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Bimschleger</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Garcia Martinez</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>George</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Gileta</surname>, <given-names>A. F.</given-names></string-name>, <string-name><surname>Han</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Horvath</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Hughson</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Ishiwari</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>King</surname>, <given-names>C. P.</given-names></string-name>, <string-name><surname>Lamparelli</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Versaggi</surname>, <given-names>C. L.</given-names></string-name>, <string-name><surname>Martin</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>St Pierre</surname>, <given-names>C. L.</given-names></string-name>, <string-name><surname>Tripi</surname>, <given-names>J. A.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Chen</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Flagel</surname>, <given-names>S. B.</given-names></string-name>, <string-name><surname>Meyer</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Richards</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Robinson</surname>, <given-names>T. E.</given-names></string-name>, <string-name><surname>Palmer</surname>, <given-names>A. A.</given-names></string-name>, <string-name><surname>Solberg Woods</surname>, <given-names>L. C</given-names></string-name></person-group>., <year>2020</year>. <article-title>Genome-Wide Association Study in 3,173 Outbred Rats Identifies Multiple Loci for Body Weight, Adiposity, and Fasting Glucose</article-title>. <source>Obesity (Silver Spring)</source> <volume>28</volume>, <fpage>1964</fpage>–<lpage>1973</lpage>.</mixed-citation></ref>
<ref id="c19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cummings</surname>, <given-names>J. A.</given-names></string-name>, <string-name><surname>Gowl</surname>, <given-names>B. A.</given-names></string-name>, <string-name><surname>Westenbroek</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Clinton</surname>, <given-names>S. M.</given-names></string-name>, <string-name><surname>Akil</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Becker</surname>, <given-names>J. B</given-names></string-name></person-group>., <year>2011</year>. <article-title>Effects of a selectively bred novelty-seeking phenotype on the motivation to take cocaine in male and female rats</article-title>. <source>Biol Sex Differ</source> <volume>2</volume>, <fpage>3</fpage>.</mixed-citation></ref>
<ref id="c20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Deroche-Gamonet</surname>, <given-names>V.</given-names></string-name>, <string-name><surname>Belin</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Piazza</surname>, <given-names>P. V</given-names></string-name></person-group>., <year>2004</year>. <article-title>Evidence for addiction-like behavior in the rat</article-title>. <source>Science</source> <volume>305</volume>, <fpage>1014</fpage>–<lpage>1017</lpage>.</mixed-citation></ref>
<ref id="c21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dews</surname>, <given-names>P. B</given-names></string-name></person-group>., <year>1955</year>. <article-title>Studies on behavior</article-title>. <source>I. Differential sensitivity to pentobarbital of pecking performance in pigeons depending on the schedule of reward. J Pharmacol Exp Ther</source> <volume>113</volume>, <fpage>393</fpage>–<lpage>401</lpage>.</mixed-citation></ref>
<ref id="c22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Domi</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Xu</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Toivainen</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Nordeman</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Gobbo</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Venniro</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Shaham</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Messing</surname>, <given-names>R. O.</given-names></string-name>, <string-name><surname>Visser</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>van den Oever</surname>, <given-names>M. C.</given-names></string-name>, <string-name><surname>Holm</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Barbier</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Augier</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Heilig</surname>, <given-names>M.</given-names></string-name></person-group>, <year>2021</year>. <article-title>A neural substrate of compulsive alcohol use</article-title>. <source>Sci Adv</source> <volume>7</volume>.</mixed-citation></ref>
<ref id="c23"><mixed-citation publication-type="preprint"><person-group person-group-type="author"><string-name><surname>Duttke</surname>, <given-names>S. H.</given-names></string-name>, <string-name><surname>Montilla-Perez</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Chang</surname>, <given-names>M. W.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Chen</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Carrette</surname>, <given-names>L. L. G.</given-names></string-name>, <string-name><surname>de Guglielmo</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>George</surname>, <given-names>O.</given-names></string-name>, <string-name><surname>Palmer</surname>, <given-names>A. A.</given-names></string-name>, <string-name><surname>Benner</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Telese</surname>, <given-names>F.</given-names></string-name></person-group>, <year>2022</year>. <article-title>Glucocorticoid Receptor-Regulated Enhancers Play a Central Role in the Gene Regulatory Networks Underlying Drug Addiction</article-title>. <source>Biorxiv</source>.</mixed-citation></ref>
<ref id="c24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Edwards</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Koob</surname>, <given-names>G. F</given-names></string-name></person-group>., <year>2013</year>. <article-title>Escalation of drug self-administration as a hallmark of persistent addiction liability</article-title>. <source>Behav Pharmacol</source> <volume>24</volume>, <fpage>356</fpage>–<lpage>362</lpage>.</mixed-citation></ref>
<ref id="c25"><mixed-citation publication-type="preprint"><person-group person-group-type="author"><string-name><surname>Eid</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Pullmann</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Thomas</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Jhou</surname>, <given-names>T. C.</given-names></string-name></person-group>, <year>2019</year>. <article-title>Multiple elements of addiction vulnerability are independently heritable in rats</article-title>. <source>Biorxiv</source>.</mixed-citation></ref>
<ref id="c26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Freeman</surname>, <given-names>K. B.</given-names></string-name>, <string-name><surname>Kearns</surname>, <given-names>D. N.</given-names></string-name>, <string-name><surname>Kohut</surname>, <given-names>S. J.</given-names></string-name>, <string-name><surname>Riley</surname>, <given-names>A. L</given-names></string-name></person-group>., <year>2009</year>. <article-title>Strain differences in patterns of drug-intake during prolonged access to cocaine self-administration</article-title>. <source>Behav Neurosci</source> <volume>123</volume>, <fpage>156</fpage>–<lpage>164</lpage>.</mixed-citation></ref>
<ref id="c27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>George</surname>, <given-names>O.</given-names></string-name>, <string-name><surname>Ahmed</surname>, <given-names>S. H.</given-names></string-name>, <string-name><surname>Gilpin</surname>, <given-names>N. W</given-names></string-name></person-group>., <year>2022</year>. <article-title>Are we compulsively chasing rainbows?</article-title> <source>Neuropsychopharmacology</source> <volume>47</volume>, <fpage>2013</fpage>–<lpage>2015</lpage>.</mixed-citation></ref>
<ref id="c28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>George</surname>, <given-names>O.</given-names></string-name>, <string-name><surname>Koob</surname>, <given-names>G. F</given-names></string-name></person-group>., <year>2017</year>. <article-title>Individual differences in the neuropsychopathology of addiction</article-title>. <source>Dialogues Clin Neurosci</source> <volume>19</volume>, <fpage>217</fpage>–<lpage>229</lpage>.</mixed-citation></ref>
<ref id="c29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>George</surname>, <given-names>O.</given-names></string-name>, <string-name><surname>Koob</surname>, <given-names>G. F.</given-names></string-name>, <string-name><surname>Vendruscolo</surname>, <given-names>L. F</given-names></string-name></person-group>., <year>2014</year>. <article-title>Negative reinforcement via motivational withdrawal is the driving force behind the transition to addiction</article-title>. <source>Psychopharmacology</source> <volume>231</volume>, <fpage>3911</fpage>–<lpage>3917</lpage>.</mixed-citation></ref>
<ref id="c30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>George</surname>, <given-names>O.</given-names></string-name>, <string-name><surname>Mandyam</surname>, <given-names>C. D.</given-names></string-name>, <string-name><surname>Wee</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Koob</surname>, <given-names>G. F</given-names></string-name></person-group>., <year>2008</year>. <article-title>Extended access to cocaine self-administration produces long-lasting prefrontal cortex-dependent working memory impairments</article-title>. <source>Neuropsychopharmacology</source> <volume>33</volume>, <fpage>2474</fpage>–<lpage>2482</lpage>.</mixed-citation></ref>
<ref id="c31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>George</surname>, <given-names>O.</given-names></string-name>, <string-name><surname>Sanders</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Freiling</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Grigoryan</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Vu</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Allen</surname>, <given-names>C. D.</given-names></string-name>, <string-name><surname>Crawford</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Mandyam</surname>, <given-names>C. D.</given-names></string-name>, <string-name><surname>Koob</surname>, <given-names>G. F</given-names></string-name></person-group>., <year>2012</year>. <article-title>Recruitment of medial prefrontal cortex neurons during alcohol withdrawal predicts cognitive impairment and excessive alcohol drinking</article-title>. <source>Proc Natl Acad Sci U S A</source> <volume>109</volume>, <fpage>18156</fpage>–<lpage>18161</lpage>.</mixed-citation></ref>
<ref id="c32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Giuliano</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Belin</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Everitt</surname>, <given-names>B. J</given-names></string-name></person-group>., <year>2019</year>. <article-title>Compulsive Alcohol Seeking Results from a Failure to Disengage Dorsolateral Striatal Control over Behavior</article-title>. <source>J Neurosci</source> <volume>39</volume>, <fpage>1744</fpage>–<lpage>1754</lpage>.</mixed-citation></ref>
<ref id="c33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hansen</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Spuhler</surname>, <given-names>K</given-names></string-name></person-group>., <year>1984</year>. <article-title>Development of the National Institutes of Health genetically heterogeneous rat stock</article-title>. <source>Alcohol Clin Exp Res</source> <volume>8</volume>, <fpage>477</fpage>–<lpage>479</lpage>.</mixed-citation></ref>
<ref id="c34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hedegaard</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Bastian</surname>, <given-names>B. A.</given-names></string-name>, <string-name><surname>Trinidad</surname>, <given-names>J. P.</given-names></string-name>, <string-name><surname>Spencer</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Warner</surname>, <given-names>M</given-names></string-name></person-group>., <year>2018</year>. <article-title>Drugs Most Frequently Involved in Drug Overdose Deaths: United States, 2011-2016</article-title>. <source>Natl Vital Stat Rep</source> <volume>67</volume>, <fpage>1</fpage>–<lpage>14</lpage>.</mixed-citation></ref>
<ref id="c35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jackson</surname>, <given-names>L. R.</given-names></string-name>, <string-name><surname>Robinson</surname>, <given-names>T. E.</given-names></string-name>, <string-name><surname>Becker</surname>, <given-names>J. B</given-names></string-name></person-group>., <year>2006</year>. <article-title>Sex differences and hormonal influences on acquisition of cocaine self-administration in rats</article-title>. <source>Neuropsychopharmacology</source> <volume>31</volume>, <fpage>129</fpage>–<lpage>138</lpage>.</mixed-citation></ref>
<ref id="c36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kallupi</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Carrette</surname>, <given-names>L. L. G.</given-names></string-name>, <string-name><surname>Kononoff</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Solberg Woods</surname>, <given-names>L. C.</given-names></string-name>, <string-name><surname>Palmer</surname>, <given-names>A. A.</given-names></string-name>, <string-name><surname>Schweitzer</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>George</surname>, <given-names>O.</given-names></string-name>, <string-name><surname>de Guglielmo</surname>, <given-names>G.</given-names></string-name></person-group>, <year>2020</year>. <article-title>Nociceptin attenuates the escalation of oxycodone self-administration by normalizing CeA-GABA transmission in highly addicted rats</article-title>. <source>Proc Natl Acad Sci U S A</source> <volume>117</volume>, <fpage>2140</fpage>–<lpage>2148</lpage>.</mixed-citation></ref>
<ref id="c37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kimbrough</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>de Guglielmo</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Kononoff</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Kallupi</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Zorrilla</surname>, <given-names>E. P.</given-names></string-name>, <string-name><surname>George</surname>, <given-names>O.</given-names></string-name></person-group>, <year>2017a</year>. <article-title>CRF1 Receptor-Dependent Increases in Irritability-Like Behavior During Abstinence from Chronic Intermittent Ethanol Vapor Exposure</article-title>. <source>Alcohol Clin Exp Res</source> <volume>41</volume>, <fpage>1886</fpage>–<lpage>1895</lpage>.</mixed-citation></ref>
<ref id="c38"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kimbrough</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>de Guglielmo</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Kononoff</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Kallupi</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Zorrilla</surname>, <given-names>E. P.</given-names></string-name>, <string-name><surname>George</surname>, <given-names>O.</given-names></string-name></person-group>, <year>2017b</year>. <article-title>CRF(1) Receptor-Dependent Increases in Irritability-Like Behavior During Abstinence from Chronic Intermittent Ethanol Vapor Exposure</article-title>. <source>Alcohol Clin Exp Res</source> <volume>41</volume>, <fpage>1886</fpage>–<lpage>1895</lpage>.</mixed-citation></ref>
<ref id="c39"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>King</surname>, <given-names>C. P.</given-names></string-name>, <string-name><surname>Tripi</surname>, <given-names>J. A.</given-names></string-name>, <string-name><surname>Hughson</surname>, <given-names>A. R.</given-names></string-name>, <string-name><surname>Horvath</surname>, <given-names>A. P.</given-names></string-name>, <string-name><surname>Lamparelli</surname>, <given-names>A. C.</given-names></string-name>, <string-name><surname>Holl</surname>, <given-names>K. L.</given-names></string-name>, <string-name><surname>Chitre</surname>, <given-names>A. S.</given-names></string-name>, <string-name><surname>Polesskaya</surname>, <given-names>O.</given-names></string-name>, <string-name><surname>Ishiwari</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Solberg Woods</surname>, <given-names>L. C.</given-names></string-name>, <string-name><surname>Palmer</surname>, <given-names>A. A.</given-names></string-name>, <string-name><surname>Robinson</surname>, <given-names>T. E.</given-names></string-name>, <string-name><surname>Flagel</surname>, <given-names>S. B.</given-names></string-name>, <string-name><surname>Meyer</surname>, <given-names>P. J</given-names></string-name></person-group>., <year>2021</year>. <article-title>Sensitivity to food and cocaine cues are independent traits in a large sample of heterogeneous stock rats</article-title>. <source>Sci Rep</source> <volume>11</volume>, <fpage>2223</fpage>.</mixed-citation></ref>
<ref id="c40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Koob</surname>, <given-names>G. F.</given-names></string-name>, <string-name><surname>Le Moal</surname>, <given-names>M.</given-names></string-name></person-group>, <year>2008</year>. <article-title>Addiction and the brain antireward system</article-title>. <source>Annu Rev Psychol</source> <volume>59</volume>, <fpage>29</fpage>–<lpage>53</lpage>.</mixed-citation></ref>
<ref id="c41"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kosten</surname>, <given-names>T. A.</given-names></string-name>, <string-name><surname>Zhang</surname>, <given-names>X. Y.</given-names></string-name>, <string-name><surname>Haile</surname>, <given-names>C. N</given-names></string-name></person-group>., <year>2007</year>. <article-title>Strain differences in maintenance of cocaine self-administration and their relationship to novelty activity responses</article-title>. <source>Behav Neurosci</source> <volume>121</volume>, <fpage>380</fpage>–<lpage>388</lpage>.</mixed-citation></ref>
<ref id="c42"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Simmler</surname>, <given-names>L. D.</given-names></string-name>, <string-name><surname>Van Zessen</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Flakowski</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Wan</surname>, <given-names>J. X.</given-names></string-name>, <string-name><surname>Deng</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>Y. L.</given-names></string-name>, <string-name><surname>Nautiyal</surname>, <given-names>K. M.</given-names></string-name>, <string-name><surname>Pascoli</surname>, <given-names>V.</given-names></string-name>, <string-name><surname>Luscher</surname>, <given-names>C.</given-names></string-name></person-group>, <year>2021</year>. <article-title>Synaptic mechanism underlying serotonin modulation of transition to cocaine addiction</article-title>. <source>Science</source> <volume>373</volume>, <fpage>1252</fpage>–<lpage>1256</lpage>.</mixed-citation></ref>
<ref id="c43"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mantsch</surname>, <given-names>J. R.</given-names></string-name>, <string-name><surname>Yuferov</surname>, <given-names>V.</given-names></string-name>, <string-name><surname>Mathieu-Kia</surname>, <given-names>A. M.</given-names></string-name>, <string-name><surname>Ho</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Kreek</surname>, <given-names>M. J</given-names></string-name></person-group>., <year>2004</year>. <article-title>Effects of extended access to high versus low cocaine doses on self-administration, cocaine-induced reinstatement and brain mRNA levels in rats</article-title>. <source>Psychopharmacology (Berl)</source> <volume>175</volume>, <fpage>26</fpage>–<lpage>36</lpage>.</mixed-citation></ref>
<ref id="c44"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Marchant</surname>, <given-names>N. J.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Shaham</surname>, <given-names>Y</given-names></string-name></person-group>., <year>2013</year>. <article-title>Recent developments in animal models of drug relapse</article-title>. <source>Curr Opin Neurobiol</source> <volume>23</volume>, <fpage>675</fpage>–<lpage>683</lpage>.</mixed-citation></ref>
<ref id="c45"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Marchette</surname>, <given-names>R. C. N.</given-names></string-name>, <string-name><surname>Carlson</surname>, <given-names>E. R.</given-names></string-name>, <string-name><surname>Said</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Koob</surname>, <given-names>G. F.</given-names></string-name>, <string-name><surname>Vendruscolo</surname>, <given-names>L. F</given-names></string-name></person-group>., <year>2023</year>. <article-title>Extended access to fentanyl vapor self-administration leads to addiction-like behaviors in mice: Blood chemokine/cytokine levels as potential biomarkers</article-title>. <source>Addict Neurosci</source> <volume>5</volume>.</mixed-citation></ref>
<ref id="c46"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Pelloux</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Everitt</surname>, <given-names>B. J.</given-names></string-name>, <string-name><surname>Dickinson</surname>, <given-names>A</given-names></string-name></person-group>., <year>2007</year>. <article-title>Compulsive drug seeking by rats under punishment: effects of drug taking history</article-title>. <source>Psychopharmacology (Berl</source>) <volume>194</volume>, <fpage>127</fpage>–<lpage>137</lpage>.</mixed-citation></ref>
<ref id="c47"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Perry</surname>, <given-names>J. L.</given-names></string-name>, <string-name><surname>Morgan</surname>, <given-names>A. D.</given-names></string-name>, <string-name><surname>Anker</surname>, <given-names>J. J.</given-names></string-name>, <string-name><surname>Dess</surname>, <given-names>N. K.</given-names></string-name>, <string-name><surname>Carroll</surname>, <given-names>M. E</given-names></string-name></person-group>., <year>2006</year>. <article-title>Escalation of i.v. cocaine self-administration and reinstatement of cocaine-seeking behavior in rats bred for high and low saccharin intake</article-title>. <source>Psychopharmacology (Berl)</source> <volume>186</volume>, <fpage>235</fpage>–<lpage>245</lpage>.</mixed-citation></ref>
<ref id="c48"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Piazza</surname>, <given-names>P. V.</given-names></string-name>, <string-name><surname>Deroche-Gamonet</surname>, <given-names>V</given-names></string-name></person-group>., <year>2013</year>. <article-title>A multistep general theory of transition to addiction</article-title>. <source>Psychopharmacology (Berl)</source> <volume>229</volume>, <fpage>387</fpage>–<lpage>413</lpage>.</mixed-citation></ref>
<ref id="c49"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Picetti</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Ho</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Butelman</surname>, <given-names>E. R.</given-names></string-name>, <string-name><surname>Kreek</surname>, <given-names>M. J</given-names></string-name></person-group>., <year>2010</year>. <article-title>Dose preference and dose escalation in extended-access cocaine self-administration in Fischer and Lewis rats</article-title>. <source>Psychopharmacology (Berl)</source> <volume>211</volume>, <fpage>313</fpage>–<lpage>323</lpage>.</mixed-citation></ref>
<ref id="c50"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Roth</surname>, <given-names>M. E.</given-names></string-name>, <string-name><surname>Carroll</surname>, <given-names>M. E</given-names></string-name></person-group>., <year>2004</year>. <article-title>Sex differences in the escalation of intravenous cocaine intake following long- or short-access to cocaine self-administration</article-title>. <source>Pharmacol Biochem Behav</source> <volume>78</volume>, <fpage>199</fpage>–<lpage>207</lpage>.</mixed-citation></ref>
<ref id="c51"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Samhsa</surname>, <given-names>A.</given-names></string-name></person-group>, <year>2019</year>. <article-title>Results from the 2018 National Survey on Drug Use and Health: Summary of national findings</article-title>. <source>Annual Report</source>.</mixed-citation></ref>
<ref id="c52"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sanger</surname>, <given-names>D. J.</given-names></string-name>, <string-name><surname>Blackman</surname>, <given-names>D. E</given-names></string-name></person-group>., <year>1976</year>. <article-title>Rate-dependent effects of drugs: a review of the literature</article-title>. <source>Pharmacol Biochem Behav</source> <volume>4</volume>, <fpage>73</fpage>–<lpage>83</lpage>.</mixed-citation></ref>
<ref id="c53"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sedighim</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Carrette</surname>, <given-names>L. L. G.</given-names></string-name>, <string-name><surname>Venniro</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Shaham</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>de Guglielmo</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>George</surname>, <given-names>O.</given-names></string-name></person-group>, <year>2021</year>. <article-title>Individual differences in addiction-like behaviors and choice between cocaine versus food in Heterogeneous Stock rats</article-title>. <source>Psychopharmacology</source> <volume>238</volume>, <fpage>3423</fpage>–<lpage>3433</lpage>.</mixed-citation></ref>
<ref id="c54"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Shansky</surname>, <given-names>R. M.</given-names></string-name>, <string-name><surname>Murphy</surname>, <given-names>A. Z</given-names></string-name></person-group>., <year>2021</year>. <article-title>Considering sex as a biological variable will require a global shift in science culture</article-title>. <source>Nat Neurosci</source> <volume>24</volume>, <fpage>457</fpage>–<lpage>464</lpage>.</mixed-citation></ref>
<ref id="c55"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Siciliano</surname>, <given-names>C. A.</given-names></string-name>, <string-name><surname>Noamany</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Chang</surname>, <given-names>C. J.</given-names></string-name>, <string-name><surname>Brown</surname>, <given-names>A. R.</given-names></string-name>, <string-name><surname>Chen</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Leible</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Lee</surname>, <given-names>J. J.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Vernon</surname>, <given-names>A. N.</given-names></string-name>, <string-name><surname>Vander Weele</surname>, <given-names>C. M.</given-names></string-name>, <string-name><surname>Kimchi</surname>, <given-names>E. Y.</given-names></string-name>, <string-name><surname>Heiman</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Tye</surname>, <given-names>K. M</given-names></string-name></person-group>., <year>2019</year>. <article-title>A cortical-brainstem circuit predicts and governs compulsive alcohol drinking</article-title>. <source>Science</source> <volume>366</volume>, <fpage>1008</fpage>–<lpage>1012</lpage>.</mixed-citation></ref>
<ref id="c56"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Solberg Woods</surname>, <given-names>L. C.</given-names></string-name>, <string-name><surname>Palmer</surname>, <given-names>A. A.</given-names></string-name></person-group>, <year>2019</year>. <article-title>Using Heterogeneous Stocks for Fine-Mapping Genetically Complex Traits</article-title>. <source>Methods Mol Biol</source> <volume>2018</volume>, <fpage>233</fpage>–<lpage>247</lpage>.</mixed-citation></ref>
<ref id="c57"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Solomon</surname>, <given-names>R. L.</given-names></string-name>, <string-name><surname>Corbit</surname>, <given-names>J. D</given-names></string-name></person-group>., <year>1974</year>. <article-title>An opponent-process theory of motivation</article-title>. <source>I. Temporal dynamics of affect. Psychol Rev</source> <volume>81</volume>, <fpage>119</fpage>–<lpage>145</lpage>.</mixed-citation></ref>
<ref id="c58"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Swalve</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Smethells</surname>, <given-names>J. R.</given-names></string-name>, <string-name><surname>Carroll</surname>, <given-names>M. E</given-names></string-name></person-group>., <year>2016</year>. <article-title>Sex differences in the acquisition and maintenance of cocaine and nicotine self-administration in rats</article-title>. <source>Psychopharmacology (Berl)</source> <volume>233</volume>, <fpage>1005</fpage>–<lpage>1013</lpage>.</mixed-citation></ref>
<ref id="c59"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Templeton</surname>, <given-names>T. J.</given-names></string-name>, <string-name><surname>Diarra</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Gilpin</surname>, <given-names>N. W.</given-names></string-name></person-group>, <year>2023</year>. <article-title>Sex differences in cocaine self-administration by Wistar rats after predator odor exposure</article-title>. <source>Adv Drug Alcohol Res</source> <volume>3</volume>.</mixed-citation></ref>
<ref id="c60"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Timme</surname>, <given-names>N. M.</given-names></string-name>, <string-name><surname>Ma</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Linsenbardt</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Cornwell</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Galbari</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Lapish</surname>, <given-names>C. C</given-names></string-name></person-group>., <year>2022</year>. <article-title>Compulsive alcohol drinking in rodents is associated with altered representations of behavioral control and seeking in dorsal medial prefrontal cortex</article-title>. <source>Nat Commun</source> <volume>13</volume>, <fpage>3990</fpage>.</mixed-citation></ref>
<ref id="c61"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Valenza</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Picetti</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Yuferov</surname>, <given-names>V.</given-names></string-name>, <string-name><surname>Butelman</surname>, <given-names>E. R.</given-names></string-name>, <string-name><surname>Kreek</surname>, <given-names>M. J</given-names></string-name></person-group>., <year>2016</year>. <article-title>Strain and cocaine-induced differential opioid gene expression may predispose Lewis but not Fischer rats to escalate cocaine self-administration</article-title>. <source>Neuropharmacology</source> <volume>105</volume>, <fpage>639</fpage>–<lpage>650</lpage>.</mixed-citation></ref>
<ref id="c62"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Vanderschuren</surname>, <given-names>L. J.</given-names></string-name>, <string-name><surname>Everitt</surname>, <given-names>B. J</given-names></string-name></person-group>., <year>2004</year>. <article-title>Drug seeking becomes compulsive after prolonged cocaine self-administration</article-title>. <source>Science</source> <volume>305</volume>, <fpage>1017</fpage>–<lpage>1019</lpage>.</mixed-citation></ref>
<ref id="c63"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Vanderschuren</surname>, <given-names>L. J.</given-names></string-name>, <string-name><surname>Minnaard</surname>, <given-names>A. M.</given-names></string-name>, <string-name><surname>Smeets</surname>, <given-names>J. A.</given-names></string-name>, <string-name><surname>Lesscher</surname>, <given-names>H. M</given-names></string-name></person-group>., <year>2017</year>. <article-title>Punishment models of addictive behavior</article-title>. <source>Current Opinion in Behavioral Sciences</source> <volume>13</volume>, <fpage>77</fpage>–<lpage>84</lpage>.</mixed-citation></ref>
<ref id="c64"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Vendruscolo</surname>, <given-names>L. F.</given-names></string-name>, <string-name><surname>Barbier</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Schlosburg</surname>, <given-names>J. E.</given-names></string-name>, <string-name><surname>Misra</surname>, <given-names>K. K.</given-names></string-name>, <string-name><surname>Whitfield</surname>, <given-names>T. W.</given-names>, <suffix>Jr.</suffix></string-name>, <string-name><surname>Logrip</surname>, <given-names>M. L.</given-names></string-name>, <string-name><surname>Rivier</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Repunte-Canonigo</surname>, <given-names>V.</given-names></string-name>, <string-name><surname>Zorrilla</surname>, <given-names>E. P.</given-names></string-name>, <string-name><surname>Sanna</surname>, <given-names>P. P.</given-names></string-name>, <string-name><surname>Heilig</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Koob</surname>, <given-names>G. F</given-names></string-name></person-group>., <year>2012</year>. <article-title>Corticosteroid-dependent plasticity mediates compulsive alcohol drinking in rats</article-title>. <source>J Neurosci</source> <volume>32</volume>, <fpage>7563</fpage>–<lpage>7571</lpage>.</mixed-citation></ref>
</ref-list>
<sec id="s5">
<title>Supplementary Figures</title>
<fig id="figs1" position="float" orientation="portrait" fig-type="figure">
<label>Figure S1.</label>
<caption><p>Additional representations of the intake and lever presses associated with <xref rid="fig1" ref-type="fig">figure 1B</xref>. A) Total number of cocaine infusions during short (2h, ShA) and long (6h, LgA) access. B) Percent of active or inactive lever presses of the total presses during short access is significantly different in every session. Mixed effects analysis shows a significant interaction between the levers and days (F<sub>(9, 2620)</sub> = 55.57, p &lt; 0.0001), the Bonferroni corrected post-hoc pairwise comparison between the percentages of both levers was significantly different on every day (***p&lt;0.0001).</p></caption>
<graphic xlink:href="453410v4_figs1.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
<fig id="figs2" position="float" orientation="portrait" fig-type="figure">
<label>Figure S2.</label>
<caption><p>Motivation (A) and compulsivity (B) for the vulnerable and resilient populations split by sex</p></caption>
<graphic xlink:href="453410v4_figs2.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
<fig id="figs3" position="float" orientation="portrait" fig-type="figure">
<label>Figure S3.</label>
<caption><p>Additional PCA analysis with the representation of the individual rats (N=377) along the first two principal components. A) Rerun the PCA from <xref rid="fig4" ref-type="fig">Fig. 4E</xref> without irritability shows escalation, motivation, and compulsivity loading onto the first PC that explains a significant portion of the variance. B) Same PCA as in <xref rid="fig4" ref-type="fig">Fig. 4E</xref>, but with the data colored according to sex [female (yellow) or male (blue)], showed no sex differences. C-D) Same PCA as in <xref rid="fig4" ref-type="fig">Fig. 4E</xref> but run on females (D) or males (D) only. E-F) Rerun the PCA from <xref rid="fig4" ref-type="fig">Fig. 4E</xref> without irritability on females (E) or males (F) only.</p></caption>
<graphic xlink:href="453410v4_figs3.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
</sec>
</back>
<sub-article id="sa0" article-type="editor-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.90422.2.sa3</article-id>
<title-group>
<article-title>eLife Assessment</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Day</surname>
<given-names>Jeremy J</given-names>
</name>
<role specific-use="editor">Reviewing Editor</role>
<aff>
<institution-wrap>
<institution>University of Alabama at Birmingham</institution>
</institution-wrap>
<city>Birmingham</city>
<country>United States of America</country>
</aff>
</contrib>
</contrib-group>
<kwd-group kwd-group-type="evidence-strength">
<kwd>Compelling</kwd>
</kwd-group>
<kwd-group kwd-group-type="claim-importance">
<kwd>Important</kwd>
</kwd-group>
</front-stub>
<body>
<p>This manuscript tackles a significant problem in addiction science: how interdependent are measures of &quot;addiction-like&quot; behavioral phenotypes? The manuscript provides <bold>compelling</bold> evidence that, under these experimental conditions, escalation of intake, punishment-resistant responding, and progressive ratio break points reflect a single underlying construct rather than reflect distinct unrelated measures. The exceptionally large sample size and incorporation of multiple behavioral endpoints add strength to this paper, and make it an <bold>important</bold> resource for the field.</p>
</body>
</sub-article>
<sub-article id="sa1" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.90422.2.sa2</article-id>
<title-group>
<article-title>Reviewer #1 (Public review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Summary:</p>
<p>Guglielmo et al. characterized addiction-like behaviors in more than 500 outbred heterogeneous stock (HS) rats using extended access to cocaine self-administration (6 h/daily) and analyzed individual differences in escalation of intake, progressive-ratio (PR) responding, continued use despite adverse consequence (contingent foot shocks), and irritability-like behavior during withdrawal. By principal component analysis, they found that escalation of intake, progressive ratio responding, and continued use despite adverse consequences loaded onto the same factor, whereas irritability-like behaviors loaded onto a separate factor. Characterization of rats in four categories of resilient, mild, moderate, and severe addiction-like phenotypes showed that females had higher addiction-like behaviors, particularly due to a lower number of resilient individuals, than males. The authors suggest that escalation of intake, continued use despite adverse consequences, and progressive ratio responding are highly correlated measures of the same psychological construct and that a significant proportion of males, but not females may be resilient to addiction-like behaviors. The amount of work in this study is impressive, and the results are interesting.</p>
<p>Strengths: Large dataset. Males and females included.</p>
</body>
</sub-article>
<sub-article id="sa2" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.90422.2.sa1</article-id>
<title-group>
<article-title>Reviewer #2 (Public review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Summary:</p>
<p>In this paper by de Guglielmo and colleagues, the authors were interested in analyzing addiction-like behaviors using a very large number of heterogeneous outbred rats in order to determine the relationships among these behaviors. The paper used both males and females on the order of hundreds of rats, allowing for detailed and complex statistical analyses of the behaviors. The rats underwent cocaine self-administration, first via 2-hour access and then via 6-hour access. The rats also underwent a test of punishment resistance in which footshocks were administered a portion of the times a lever was pressed. The authors also conducted a progressive ratio test to determine the break point for &quot;giving up&quot; pressing the lever and a bottle-brush test to determine the rats &quot;irritability&quot;. Ultimately, principal component analysis revealed that escalation of intake during 6-hour access, punishment resistance, and breakpoint all loaded onto the same principal component. Moreover, the authors also identified a subgroup of &quot;resilient&quot; rats that qualitatively differed from the &quot;vulnerable&quot; rats and also identified sex differences in their work.</p>
<p>Strengths:</p>
<p>The use of heterogeneous rats and the use of so many rats are major strengths for this paper. Moreover, the statistical analyses are particular strengths as they enabled the identification of the three measures as likely reflecting a single underlying construct. The behavioral methods themselves are also strong, as the authors used behavioral measures commonly used in the field that will enable comparison with the field at large. In general, the results support the conclusions and provide a wealth of data to the field. The addition of effect sizes is also a strength, as this provides critical information to other researchers.</p>
<p>Additionally, the changes made to the manuscript are another strength, as the authors clearly took the reviewers' points seriously and made strong efforts incorporate the reviewers' ideas.</p>
<p>The manuscript also uses both males and females and provides a good analysis of how findings differed by sex as well as how large the effect sizes were for those differences.</p>
</body>
</sub-article>
<sub-article id="sa3" article-type="author-comment">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.90422.2.sa0</article-id>
<title-group>
<article-title>Author response:</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>de Guglielmo</surname>
<given-names>Giordano</given-names>
</name>
<role specific-use="author">Author</role>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4782-7430</contrib-id></contrib>
<contrib contrib-type="author">
<name>
<surname>Carrette</surname>
<given-names>Lieselot LG</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kallupi</surname>
<given-names>Marsida</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Brennan</surname>
<given-names>Molly</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Boomhower</surname>
<given-names>Brent</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Maturin</surname>
<given-names>Lisa</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Conlisk</surname>
<given-names>Dana</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sedighim</surname>
<given-names>Sharona</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tieu</surname>
<given-names>Lani</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fannon</surname>
<given-names>McKenzie J</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Martinez</surname>
<given-names>Angelica R</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Velarde</surname>
<given-names>Nathan</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Othman</surname>
<given-names>Dyar</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sichel</surname>
<given-names>Ben</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ramborger</surname>
<given-names>Jarryd</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lau</surname>
<given-names>Justin</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kononoff</surname>
<given-names>Jenni</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kimbrough</surname>
<given-names>Adam</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Simpson</surname>
<given-names>Sierra</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Smith</surname>
<given-names>Lauren C</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shankar</surname>
<given-names>Kokila</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bonnet-Zahedi</surname>
<given-names>Selene</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sneddon</surname>
<given-names>Elizabeth A</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Avelar</surname>
<given-names>Alicia</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Plasil</surname>
<given-names>Sonja L</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mosquera</surname>
<given-names>Joseph</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Crook</surname>
<given-names>Caitlin</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chun</surname>
<given-names>Lucas</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vang</surname>
<given-names>Ashley</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Milan</surname>
<given-names>Kristel K</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Schweitzer</surname>
<given-names>Paul</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lin</surname>
<given-names>Bonnie</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Peng</surname>
<given-names>Beverly</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chitre</surname>
<given-names>Apurva</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Polleskaya</surname>
<given-names>Oksana</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Solberg Woods</surname>
<given-names>Leah C</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Palmer</surname>
<given-names>Abraham A</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>George</surname>
<given-names>Olivier</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>The following is the authors’ response to the original reviews.</p>
<disp-quote content-type="editor-comment">
<p><bold>Reviewer #1:</bold></p>
<p>(1) Adding page numbers would have helped the reviewers.</p>
</disp-quote>
<p>We apologize for the oversight and have added page numbers for the revision.</p>
<disp-quote content-type="editor-comment">
<p>(2) Page 2, second paragraph: please do not generalize. Also, this sentence is confusing: &quot;the addiction neuroscience field has moved from recognizing that &quot;compulsive drug seeking/use&quot; and &quot;continued seeking/use despite negative consequences&quot; are two distinct aspects of addiction to defining the former nearly exclusively by the latter in animal models.&quot;</p>
</disp-quote>
<p>We acknowledge that the sentence in question may have been unclear. We have revised the introduction to avoid generalizations and improve clarity to read:</p>
<p>“Recently, the preclinical addiction field has moved from recognizing compulsive drug seeking/use and continued seeking/use despite negative consequences as two distinct aspects of addiction, to examining compulsive-like behavior nearly exclusively by models of continued seeking/use despite negative consequences.”</p>
<p>In the revised introduction, we have focused on the specific aims and findings of our study, emphasizing the use of a large, genetically diverse sample and an extended drug access paradigm to better model addiction-like behaviors. We have also clarified the relationship between the different measures of addiction-like behavior and the potential role of sex differences in resilience to these behaviors.</p>
<disp-quote content-type="editor-comment">
<p>(3) Again here, please do not generalize: &quot;While these three behaviors capture different aspects of addictionlike behaviors, a pervasive view in the field is that the only way to identify an individual with an addiction phenotype is to measure continued drug use despite adverse consequences.&quot; This is not unanimous in the addiction field. Same on page 21.</p>
</disp-quote>
<p>We have revised the sentence to avoid generalizing and to acknowledge that this perspective is held by some researchers, rather than presenting it as a pervasive view. We have also included relevant citations to support this point. This sentence now reads:</p>
<p>“These measures are thought to capture different aspects of addiction-like behaviors. Some researchers argue that continued drug use despite adverse consequences is the most critical measure for identifying an addiction phenotype, as it reflects the compulsive nature of drug use (Deroche-Gamonet et al., 2004; Vanderschuren and Everitt, 2004)”</p>
<disp-quote content-type="editor-comment">
<p>(4) This sentence needs citations: &quot;A key argument in favor of this hypothesis is that responding despite adverse consequences is sometimes uncorrelated to drug taking/seeking.&quot;</p>
</disp-quote>
<p>We have added references (Chen et al., 2013; Domi et al., 2021; Giuliano et al., 2019; Li et al., 2021; Siciliano et al., 2019; Timme et al., 2022; Belin et al., 2008; Pelloux et al., 2007) that provide evidence for this assertion. These studies demonstrate that individual differences in responding despite adverse consequences can be dissociated from drug intake and seeking behaviors, suggesting that they may measure distinct aspects of addiction-like behaviors.</p>
<disp-quote content-type="editor-comment">
<p>(5) Page 4: what is &quot;an advanced model?&quot; (also on page 22). Change &quot;characterization&quot; to &quot;characterized.&quot; Delete &quot;as much as possible&quot; in &quot;as much genetic diversity as possible.&quot;</p>
</disp-quote>
<p>These have been addressed</p>
<disp-quote content-type="editor-comment">
<p>(6) Page 7, statistical analysis: PCA needs to be explained further. Was the PCA varimax rotated, normalized, eigenvalues, etc. Was this used to find &quot;latent variables?&quot; (PCA versus factor analysis)</p>
</disp-quote>
<p>It was a principal component analysis (PCA), deriving components that are a linear combination of the original variables, with the following coefficients for the first two components, which were added in the results for PC1:</p>
<table-wrap id="sa3table1">
<label>Author response table 1.</label>
<graphic mime-subtype="jpg" xlink:href="elife-90422-sa3-table1.jpg" mimetype="image"/>
</table-wrap>
<p>The PCA was performed in R with prcomp in the stats package, using centering and scaling, which was added in the methods section. No orthogonal loadings rotation (varimax) was used. The eigenvalues of the PCs are 1.9, 1.0, 0.7, 0.4 and explain variance as shown in the scree plot:</p>
<fig id="sa3fig1">
<label>Author response image 1.</label>
<graphic mime-subtype="jpg" xlink:href="elife-90422-sa3-fig1.jpg" mimetype="image"/>
</fig>
<disp-quote content-type="editor-comment">
<p>(7) Page 9: correct &quot;an indexes.&quot;</p>
</disp-quote>
<p>This was corrected as ‘indexes’</p>
<disp-quote content-type="editor-comment">
<p>(8) Figure 1 legend: correct &quot;test at the.&quot;</p>
</disp-quote>
<p>Corrected to ‘tested’</p>
<disp-quote content-type="editor-comment">
<p>(9) Page 17: rewrite &quot;except for the low addicted one.&quot;</p>
</disp-quote>
<p>Done</p>
<disp-quote content-type="editor-comment">
<p>(10) Page 19: delete &quot;state-of-the-art.&quot; Intravenous self-administration is not new.</p>
</disp-quote>
<p>Done</p>
<disp-quote content-type="editor-comment">
<p>(11) Page 20: replace &quot;abuse&quot; with cocaine use disorder.</p>
</disp-quote>
<p>Done</p>
<disp-quote content-type="editor-comment">
<p>(12) Page 20: The distinction of qualitative and quantitative differences between males and females is inaccurate given that resilient and vulnerable groups were arbitrarily defined by quantitative differences.</p>
</disp-quote>
<p>This distinction between quantitative and qualitative was removed.</p>
<disp-quote content-type="editor-comment">
<p>(13) The discussion about DSM-V criteria is &quot;over the top&quot; and unnecessary. One cannot determine whether rodents took more drugs than intended, made efforts to quit, etc.</p>
</disp-quote>
<p>This discussion was toned down and shortened, as this is not the focus of the manuscript.</p>
<disp-quote content-type="editor-comment">
<p>(14) Page 21: The discussion about small n and the test of nondependent rats should also be toned down and it is incomplete. There are several behavioral and pharmacological studies that indicate that different measures may capture, at least to some degree, different aspects of behavior in alcohol and opioid-dependent rodents (e.g., PMID: 28461696; PMID: 25878287; PMID: 36683829).</p>
</disp-quote>
<p>the discussion has been toned down and expanded as suggested by the reviewer.</p>
<p>Now it reads:</p>
<p>“A possible explanation as to why previous studies failed to observe this correlation between escalation, motivation, and aversion-resistance is that most of the previous studies used small sample sizes that may not provide sufficient statistical power to observe this relationship between variables. Another explanation is that previous studies often used animal models with limited access to the drug, where animals exhibit low levels of acute intoxication and very little, if any, signs of drug dependence (George et al., 2022). However, it is important to note that several behavioral and pharmacological studies have indicated that different measures may capture, at least to some degree, different aspects of addiction-like behavior in alcohol and opioid-dependent rodents (Aoun et al., 2018; Barbier et al., 2015; Marchette et al., 2023). While the present results suggest that escalation of drug intake highly predicts drug responding despite adverse consequences in an animal model with long access to cocaine and evidence of drug dependence, further research is needed to determine the extent to which these findings generalize to other drugs of abuse and different stages of the addiction cycle”.</p>
<disp-quote content-type="editor-comment">
<p>(15) Several factors should be considered for explaining their PCA findings. The progression of the progressive ratio (too steep, not steep enough), the shock intensity (too low, too high), the contingency of the shock (high or not high enough), the cocaine unit dose, the use of multiple punishment sessions (learning; the first session is likely to reflect the previous session, same for PR) etc, all could affect the outcomes. Not finding differences in one dataset (even large ones) obtained from a particular experimental design does not necessarily mean that these differences do not exist.</p>
</disp-quote>
<p>Thank you for raising this important point about the potential impact of experimental factors on our PCA findings. We now acknowledge in the discussion (pages 22-23) that several factors, such as the progression of the progressive ratio schedule, shock intensity, contingency of the shock, cocaine unit dose, and the use of multiple punishment sessions, could influence the outcomes of our analysis. Now it reads:</p>
<p>“It is important to acknowledge that several experimental factors could influence the outcomes of the PCA analysis. These factors include the schedule of reinforcement, the progression of the progressive ratio schedule, the shock intensity, the contingency of the shock, the cocaine unit dose, and the use of multiple punishment sessions (Belin et al., 2008; Deroche-Gamonet et al., 2004; Pelloux et al., 2007). In particular, learning effects may play a role when animals undergo multiple punishment or progressive ratio sessions. An animal's response to punishment or its performance in progressive ratio sessions may change over time as it learns from its previous experiences (Marchant et al., 2013; Vanderschuren et al., 2017). While the present study utilized a large dataset obtained from a particular experimental design, it is essential to acknowledge that not finding differences in one dataset does not necessarily mean that these differences do not exist. Future studies should investigate the impact of these experimental factors, including learning effects, on the relationship between escalation, motivation, and aversion-resistance to further elucidate the underlying constructs of addiction-like behaviors.”</p>
<disp-quote content-type="editor-comment">
<p>(16) Related to the above, another reason for all &quot;consummatory variables&quot; to load onto the same factor can be due to the selection of the variables. For example, the inclusion of all ShA and LgA access sessions makes the PCA much less powerful. In fact, these many similar variables would make the PCA less powerful in a large dataset than a much smaller dataset that includes fewer variables in the PCA. The authors should attempt to avoid redundant variables in the PCA (all ShA and all LgA sessions). Perhaps use the average of the last three sessions of each ShA and LgA (or the slope of the escalation curve for LgA), or not even include ShA. They should also attempt PCAs without the irritability test. It is very common to find clusters of variables pertaining to the same tests (i.e., all consummatory variables clustered together, and all irritability measures clustered together in an independent factor.</p>
</disp-quote>
<p>For the PCA in figure 4E, only 4 variables were included: the Z-scores for A) escalation (calculated as the average intake of the last three long-access sessions, similar to the average or slope of the escalation curve as suggested by the reviewer), B) motivation (intake under progressive ratio), C) compulsivity (continued responding despite adverse consequences), and D) irritability. This approach aimed to minimize redundancy in the variables and focus on key measures of addiction-like behaviors.</p>
<p>To further address the reviewer's concern, we performed an additional PCA on the same 377 animals, excluding the irritability index. This PCA included only the escalation, motivation, and compulsivity indices. The results of this analysis (Figure S3A) were consistent with our original findings, with the three variables loading similarly (&gt;+1 standard deviation) onto factor 1 explaining 63.5% of the variance in addiction-like behaviors.&quot; This analysis was added as supplementary figure S3A.</p>
<disp-quote content-type="editor-comment">
<p>(17) Also related to the above, males and females may behave differently, sometimes in opposite directions, thus &quot;cancel each other out.&quot; The authors should take advantage of their huge sample size and do PCAs separately for males and females to learn more about potential sex differences in behavioral constructs.</p>
</disp-quote>
<p>First, we looked at male vs. female differences in the biplot represented in Fig. 4E, which included the irritability index. This analysis showed no sex differences and was added as supplemental figure S3B.</p>
<p>Next, we ran the PCA analysis on males (left panel) and females (right panel) separately, which revealed a difference in the relationship between the Compulsivity Index and the other variables. In males, the Compulsivity Index separated from the escalation and motivation indices in the opposite direction relative to PC2 compared to females. Additionally, in males, compulsivity became more positively correlated with irritability, while in females, the relationship was opposite. These interpretations were added to the discussion page 21 and the results were included in the Supplemental Figure S3 C-D. The discussion was updated accordingly.</p>
<disp-quote content-type="editor-comment">
<p>(18) Figure 3 legend. There is no correlation in the figure.</p>
</disp-quote>
<p>This was intended to summarize that vulnerable animals, as defined with a high intake in the last 3 LgA sessions are also more vulnerable in the other measures, but was removed to avoid further confusion.</p>
<disp-quote content-type="editor-comment">
<p>(19) Page 22: the authors contradict themselves: &quot;The evaluation of different addiction-like behaviors is important as multiple elements of addiction vulnerability were found to be independently heritable (Eid et al., 2019), and likely controlled by distinct genes that remain to be identified.&quot;</p>
</disp-quote>
<p>we agree with the reviewer, and we edited the discussion to clarify the relationship between the current findings and the potential for distinct genetic influences on different aspects of addiction vulnerability. The text now reads:</p>
<p>“The evaluation of different addiction-like behaviors is important, as previous research has suggested that multiple elements of addiction vulnerability may be independently heritable (Eid et al., 2019). While our current findings indicate that escalation, motivation, and compulsivity are highly correlated and load onto a single construct in our model, it is possible that distinct genes contribute to different aspects of addiction vulnerability. The high correlation between these behaviors in our study may reflect common underlying genetic influences, but it does not preclude the existence of additional, unique genetic factors that shape specific aspects of addiction-like behavior. Further research is needed to identify the specific genes that contribute to the overall construct of addiction vulnerability, as well as those that may influence distinct behavioral elements. The behavioral characterization of HS rats in this study provides a foundation for future genome-wide association studies (GWAS) aimed at identifying specific alleles and genes that contribute to vulnerability and resilience to cocaine addiction-like behavior (Chitre et al., 2020).”</p>
<disp-quote content-type="editor-comment">
<p><bold>Reviewer #2</bold>:</p>
<p>(1) I strongly suggest the authors include effect sizes. They are likely correct that many studies using rats during self-administration are underpowered, but because it is unlikely that most studies will use over 500 rats, the effect size information would be beneficial for future researchers. That is, if an effect requires 100 rats per group, this would be critical to know.</p>
</disp-quote>
<p>Standardized effect sizes (Cohen d and 95% confidence intervals) were included for the sex differences, intake group differences, and addiction groups. Moreover, a statement about the required amount of animals needed to detect significant effects was added in the discussion.</p>
<disp-quote content-type="editor-comment">
<p>(2) I suggest that the authors tone down the portions of the Discussion that appear to be defenses of the extended access model. The data in this paper do not address short vs. long-access in a way that supports that. Moreover, they should acknowledge some of the ways that I noted above in which the short access period seems to be just as predictive as the long-access. It raises the question of whether keeping another group of rats on short access through all 25 days would have led to some of the same outcomes that were observed.</p>
</disp-quote>
<p>This discussion was toned down and shortened, as this is also not the focus of the manuscript (see also response to reviewer 1’s 14th comment).</p>
<p>We appreciate the reviewer's comment on the potential predictive value of the short access period for addiction-like behaviors. We agree that maintaining a group of rats on short access throughout the 25 days could have provided valuable insights into the development of these behaviors, particularly in light of the individual differences observed in our genetically diverse HS rat population. As we mention also in our response to Reviewer 3 (comment 5), the observed escalation of drug intake during the short access condition in our study may be attributed to the genetic diversity of the HS rat population. To address this important point, we have added a new paragraph in the Discussion section that elaborates on this observation:</p>
<p>&quot;It is important to note that while our study focused on the differences between resilient and vulnerable rats under long access conditions, the short access period may also be predictive of addiction-like behaviors, particularly in genetically diverse populations. The observed escalation of drug intake during short access in our study is not due to an acquisition issue, as rats start differentiating the active from the inactive levers on the first day of ShA1 (Fig. S1B), with a 3 to 1 ratio between active/inactive pressing by ShA7. Rather, this early escalation may be attributed to the individual differences in drug-taking behavior among the HS rats, highlighting the importance of using genetically diverse animals to capture the full spectrum of individual differences in addiction-like behaviors.&quot;</p>
<disp-quote content-type="editor-comment">
<p>(3) I suggest the authors explain how the dosing was maintained across the self-administration period. I also suggest that the authors provide figures that show mg/kg of cocaine consumed for each day, rather than just infusions per day. This would be especially helpful for the sex difference claims.</p>
</disp-quote>
<p>To ensure consistent dosing, animals were weighed weekly to adjust the drug solution concentration, rounded to the nearest ten grams. This sentence was added to the methods section. Each infusion is 0.5 mg/kg, so the amount the animals consumed = number of infusions x 0.5 mg/kg. Moreover, a second axis with the dose in mg/kg of cocaine consumed was added to the escalation curves in figures 1B, 2A, 3A, 5A, and S1A.</p>
<disp-quote content-type="editor-comment">
<p>(4) Throughout the paper, and especially the 2nd paragraph of the Introduction, the authors make a number of assertions for which they should provide references.</p>
</disp-quote>
<p>We have carefully reviewed the manuscript and have now included relevant references to ensure that all statements are properly supported by the existing literature.</p>
<disp-quote content-type="editor-comment">
<p>(5) Likewise, with the Discussion about sex and gender differences, I suggest a more nuanced and better-cited discussion. Many rodent studies with self-administration have not identified sex differences, though this often gets under-noticed as the titles and abstracts do not mention the lack of effects. The support for gender differences in humans in terms of vulnerability to cocaine use disorder, beyond that men have higher rates, is thin and this section should be modified.</p>
</disp-quote>
<p>The section was modified with additional references and linked to the newly introduced effect sizes for sex differences.</p>
<disp-quote content-type="editor-comment">
<p>(6) I also suggest the authors change some of the language such as referring to their behavioral measures as &quot;state of the art&quot;. Extended access has been around for over two decades.</p>
</disp-quote>
<p>This has been adjusted, also see response to reviewer 1’s comments on page 4, 19, and 22.</p>
<disp-quote content-type="editor-comment">
<p><bold>Reviewer #3:</bold></p>
<p>Strengths:</p>
<p>(1) The number of animals run through this study is particularly impressive and allows for analyses that cannot be done with smaller cohorts.</p>
<p>(2) The inclusion of males and females in a study of this size allows for a better understanding of potential sex differences across a range of behavioral domains.</p>
<p>(3) Relating these measures to each other is incredibly important. If they are all measuring the same thing this would have important implications for the field.</p>
<p>Weaknesses:</p>
<p>(1) The authors claim that escalation of intake, increased motivation under progressive ratio, and responding despite negative consequences can all be explained by the same psychological construct, which they conclude is predictive of an addiction-like phenotype. However, previous research has demonstrated that the aforementioned behavioral measures highly correlate with the rate at which animals lever press to receive a reinforcer. For example, animals that have higher baseline rates of behavior will also be less sensitive to punishment and will press more on a PR. In fact, early behavioral pharmacology work from Peter Dews showed that the same is true for drug effects on behavior, where the same drug has less of a behavioral effect with behavior was maintained on a schedule that resulted in higher response rates. This is not ruled out and actually could explain the results in a parsimonious way. This is not highlighted or mentioned in the manuscript.</p>
</disp-quote>
<p>Thank you for raising this important point about the potential influence of baseline response rates on the observed correlations between addiction-like behaviors. We agree that individual differences in baseline response rates may contribute to the relationships we observed, and we have added a paragraph to the discussion acknowledging this possibility (see page 22). We now discuss how previous research has shown that animals with higher baseline rates of responding tend to be less sensitive to punishment and exhibit higher levels of responding under progressive ratio schedules, as demonstrated in early behavioral pharmacology work by Dews and others (Dews, 1955; Sanger and Blackman, 1976). While our findings suggest that escalation of intake, motivation, and responding despite negative consequences can be explained by a single psychological construct related to addiction vulnerability, we cannot rule out the influence of baseline response rates. We have highlighted the need for future studies to investigate the relationship between baseline response rates and addiction-like behaviors to further clarify the underlying mechanisms</p>
<disp-quote content-type="editor-comment">
<p>(2) The authors draw major conclusions from data collected using only one dose of cocaine. Can the authors comment on how the dose of cocaine was selected? Although the majority of the animals maintained responding to the drug, one finding of the manuscript claims that roughly 20% of animals were resilient to developing an addiction-like phenotype. The differences observed could simply be a result of selecting too high or too low of a dose per infusion.</p>
</disp-quote>
<p>We selected a dose of 0.5 mg/kg/infusion of cocaine for our study based on our and others previous literature demonstrating that this dose is commonly used in rat self-administration studies and is effective in producing addiction-like behaviors (de Guglielmo et al. 2017, Kallupi et al. 2022, Kononoff et al. 2018, Sedighim et al. 2021, Ahmed and Koob, 1998; Deroche-Gamonet et al., 2004; Belin et al., 2009). This dose has been shown to maintain stable responding and induce escalation of intake, motivation, and compulsive-like responding in a significant proportion of animals (Ahmed and Koob, 1998; DerocheGamonet et al., 2004; Belin et al., 2009).</p>
<disp-quote content-type="editor-comment">
<p>(3) In line with the previous comment, rats self-administered cocaine under one schedule of reinforcement and were exposed to only one, mild, foot shock intensity. Although a large number of animals were used, it is difficult to translate these results to understand patterns of drug intake in humans.</p>
</disp-quote>
<p>We appreciate the reviewer's comment on the limitations of using a single schedule of reinforcement and a single foot shock intensity in our study. We acknowledge that these factors may limit the direct translatability of our findings to patterns of drug intake in humans. As mentioned in our response to Reviewer 1 (comment 15), we have now added a paragraph to the discussion (pages 22-23) addressing the potential impact of various experimental factors on our PCA findings. These factors include the schedule of reinforcement, the progression of the progressive ratio schedule, shock intensity, contingency of the shock, cocaine unit dose, and the use of multiple punishment sessions. We acknowledge that the specific parameters used in our study may have influenced the observed individual differences in addiction-like behaviors and that different results might be obtained under different experimental conditions. To further address the current reviewer's concern, we would like to emphasize that our study aimed to investigate individual differences in addiction-like behaviors within a specific experimental context, rather than directly modeling the complex patterns of drug intake in humans. While our findings provide valuable insights into the relationship between different addiction-like behaviors in rats, we agree that additional studies using a range of experimental conditions are needed to fully understand the extent to which these findings translate to human drug use patterns. Future studies could investigate the impact of different schedules of reinforcement, shock intensities, and other experimental parameters on the development and expression of addiction-like behaviors in the HS rat population. Such studies would help to determine the generalizability of our findings and provide a more comprehensive understanding of the factors influencing individual differences in addiction vulnerability.</p>
<disp-quote content-type="editor-comment">
<p>(4) It is unclear how a principal component analysis, which includes irritability-like behavior, was conducted when the total number of animals used for behavior is nearly half the number of animals used for drugintake behaviors. The authors should expand on the PCA methodology and explain how that is not a problem for the PCA method that is used.</p>
</disp-quote>
<p>The PCA (Figure 4E) can only be performed using animals that had the data for all measures, including irritability. Since not all animals were tested for irritability-like behaviors the PCA was performed on those 377 animals who had behavioral measures for all variables. Once irritability was excluded as a measure, the larger animal set could be used (including the animals missing irritability measurements). This was clarified in the text and figure legend, where animal numbers were added.</p>
<disp-quote content-type="editor-comment">
<p>(5) It is surprising that the authors observed an escalation of drug intake during the short access condition (Fig. 1B, 2A, 3A, 5A). Previous literature has demonstrated that animals with short access to cocaine maintain stable and low intake, even when tested daily for weeks. Can the authors comment on this discrepancy? Are these animals still acquiring the task during this period?</p>
</disp-quote>
<p>We were indeed surprised by the fact that some individuals started escalating their intake early on during short access, as most of the literature shows that short access leads to stable intake. However, we have some hypotheses that may explain this phenomenon. It is unlikely that this early escalation is due to an acquisition issue as rats start differentiating the active from the inactive levers on the first day of ShA1 (new data included as Fig. S1B) and that there is a 3 to 1 ratio between active/inactive pressing by ShA7. Three factors are more likely to play a key role in this early escalation. First, it is likely that the early escalation observed in some animals is due to the genetic diversity of the HS rat population used in our study. Indeed, most of the literature used Wistar, Sprague Dawley, and Long Evans rats, while the HS rats includes 8 different strains as founder parents. Indeed, profound strain differences have been observed in the vulnerability to self-administer cocaine, the maintenance of cocaine self-administration during short access,  and the level of escalation of intake (Freeman et al., 2009; Kosten et al., 2007; Perry et al., 2006; Picetti et al., 2010; Valenza et al., 2016). Second, we used a 2 h short access while most studies used 1 h of short access. The level of escalation is proportional to the duration of access, and it is likely that a 1 h access period leads to a ceiling effect preventing detection of individual differences in early escalation. Third, it is likely that reporting and publication bias played a significant role in the lack of reporting of such a phenomenon. When using a low sample size, many laboratories remove outliers during short access to ensure a homogeneous population before being given long access or moving on to a specific experimental condition. The combination of using a limited number of strains with limited genetic diversity, a 1h short access, and reporting bias is likely to have led to the conclusion that escalation of cocaine intake does not occur during short access. The current report using a rat stock with high genetic diversity, a 2 h short access, and no reporting bias conclusively demonstrates that escalation of cocaine intake occurs in some individuals. The discussion has been updated to reflect these points on page 20.</p>
<disp-quote content-type="editor-comment">
<p>(6) Although the authors provide PR and foot shock data separated by sex in Supplemental Figure 2, the manuscript would benefit from denoting the number of males and females in each data set shown in Figures 3 and 5. Is there a difference in the proportion of males or females that display a vulnerable phenotype? Given that the authors are interested in investigating sex differences, it would greatly improve the manuscript to disaggregate the resilient/vulnerable data (Figure 3) and degree of vulnerability data (Figure 5) by sex.</p>
</disp-quote>
<p>We have now added the proportion of males and females in each of these subgroups and discussed these results.</p>
<p>- For figure 3: when categorizing on intake, there is a greater number of males in the Resilient population than females, as a logical conclusion from the findings in figure 2. The following was added: “From the analysis of sex differences above, we could expect the Resilient group to contain more males. Amongst the resilient animals, there were twice as many males compared to females (N = 122 total with 82 males and 40 females). The amounts in the vulnerable group were almost equal (N = 445 total with 210 males and 235 females).</p>
<p>- For figure 5: as the z-scoring of the behavioral measures is performed per sex, these differences are normalized, and all groups contain equal amounts of males and females. The following was added: “As the indices were derived per sex, quantile normalization results in roughly equal number of males and females in each group: 57 females and 71 males in the Low group, 68 females and 60 males in the Mild group, 67 females and 60 males in the Moderate group, and 57 females and 71 males in the Severe group.” To make this clearer, we also elaborated on the calculation of the indices in the methods and results sections.</p>
<disp-quote content-type="editor-comment">
<p>(7) Consistent with previous reports, the authors demonstrate an increase in irritability-like behavior during withdrawal after cocaine self-administration; however, they make the claim that this variable was orthogonal to drug intake behavior. The discussion claims that the increase in irritability-like behavior was likely due to factors independent of drug intake, such as undergoing surgery, catheter implants, or being tested daily for two months. Individuals with a history of substance use disorder are thought to continue use as a consequence of negative reinforcement. Unwanted behavioral states, such as irritability, can be a driving factor in relapse; therefore, it would perhaps be more translationally relevant to understand the degree to which irritability-like behavior acts as a negative reinforcer rather than correlating this behavior with initial drug-seeking behavior. While this is outside of the scope of the current manuscript, perhaps this is worth noting in the discussion.</p>
</disp-quote>
<p>the reviewer raises a good point and we added a paragraph to the discussion acknowledging the translational relevance of understanding the relationship between irritability and drug-seeking behavior in the context of negative reinforcement and relapse. Now it reads:</p>
<p>“Despite the lack of correlation between irritability-like behavior and drug intake in our study, it is important to consider the translational relevance of irritability in the context of substance use disorders. In individuals with a history of substance use disorder, negative affective states, such as irritability, are thought to contribute to continued drug use and relapse through negative reinforcement processes (Baker et al., 2004; Koob and Le Moal, 2008). Specifically, the desire to alleviate or escape from these unwanted behavioral states may drive individuals to seek and use drugs, thus perpetuating the cycle of addiction (Baker et al., 2004; Solomon and Corbit, 1974). While our study focused on the relationship between irritability-like behavior and initial drug-seeking behavior, future research should investigate the degree to which irritability acts as a negative reinforcer in the context of drug relapse”.</p>
</body>
</sub-article>
</article>